Page last updated: 2024-11-06

prednisolone and Diffuse Mixed Small and Large Cell Lymphoma

prednisolone has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 478 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"A 49-year-old-man, a healthy carrier of hepatitis B virus (HBV), received chemotherapy with a rituximab/cyclo- phosphamide/doxorubicin/vincristine/prednisolone (R-CHOP) regimen for non-Hodgkin's lymphoma."7.75[A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma]. ( Kitada, N; Kobayashi, M; Kondo, M; Mori, A; Morita, S; Okamoto, T; Tsuji, T; Watari, M; Yoshioka, M, 2009)
"Hypercalcemia in a 4-year-old boy with non-Hodgkin lymphoma treated with pamidronate is presented."7.69Childhood cancer and hypercalcemia: report of a case treated with pamidronate. ( Akyüz, C; Büyükpamukçu, M; Hazar, V; Kutluk, MT; Varan, A, 1997)
"Six courses of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) or cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone (CHOEP) chemotherapy were recommended for first-line therapy of patients with nodal, intestinal or hepatosplenic T-cell lymphomas (evidence: low; recommendation: do, weak)."3.80SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. ( Barosi, G; Billio, A; Corradini, P; Gallamini, A; Marchetti, M; Pileri, S; Pimpinelli, N; Rossi, G; Tura, S; Zinzani, PL, 2014)
" Toxic encephalopathy was diagnosed in 6 (10%) patients with acute leucosis treated by endolumbal administration of metotherxate, cytarabine and prednisolone (to prevent neuroleukemia) and in 2 (8%) patients with non-Hodgkin lymphomas."3.78[Lesions in the nervous system during chemotherapy of acute leukosis and non-Hodgkin lymphomas]. ( Zyrina, GV, 2012)
"A 49-year-old-man, a healthy carrier of hepatitis B virus (HBV), received chemotherapy with a rituximab/cyclo- phosphamide/doxorubicin/vincristine/prednisolone (R-CHOP) regimen for non-Hodgkin's lymphoma."3.75[A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma]. ( Kitada, N; Kobayashi, M; Kondo, M; Mori, A; Morita, S; Okamoto, T; Tsuji, T; Watari, M; Yoshioka, M, 2009)
"We describe a patient with non-Hodgkin's lymphoma treated with a chemotherapy regimen (which included bleomycin, prednisolone and low-dose methotrexate) who developed cutaneous non-caseating granulomas."3.70Cutaneous granulomas associated with high-grade T-cell non-Hodgkin's lymphoma. ( Cream, JJ; Farrell, AM; Francis, N; Henry, K; Mitchell, DN; Newlands, ES; Woodrow, D, 1999)
"Hypercalcemia in a 4-year-old boy with non-Hodgkin lymphoma treated with pamidronate is presented."3.69Childhood cancer and hypercalcemia: report of a case treated with pamidronate. ( Akyüz, C; Büyükpamukçu, M; Hazar, V; Kutluk, MT; Varan, A, 1997)
" Four case reports are presented; 3 lymphomas and 1 multiple myeloma that developed, in heart transplant recipients receiving triple-drug immunosuppression: azathioprine, cyclosporine and prednisolone."3.68[Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases]. ( Burtin, P; Guerci, AP; Lederlin, P; Mattei, S, 1992)
"Prednisolone (PRED) was given at the fixed dose of 60 mg/m(2) (IV or orally) on days 1-5."2.79A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial. ( Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P, 2014)
" Patients with previously untreated aggressive NHL were randomized to receive either eight cycles of (R)CHOP given every 3 wk or (R)CHOP combined with gemcitabine [Gem-(R)CHOP]."2.76Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54). ( Aurer, I; Baila, L; Eghbali, H; Fortpied, C; Khaled, HM; Raemaekers, J; van der Maazen, RW, 2011)
"Grade 3 and 4 infections occurred four times more frequently in the dose-dense arm."2.75Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma. ( Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E, 2010)
"Treatment with etoposide also evolved as a prognostic factor because the risk of CNS failure was significantly reduced after CHOEP (P=0."2.73Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S, 2007)
"3HCL, a potent inhibitor of P-glycoprotein (P-gp), when administered orally alone and in combination with the CHOP regimen in patients with untreated non-Hodgkin's lymphoma and to determine whether zosuquidar."2.73Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma. ( Bouafia, F; Burgess, M; Dumontet, C; Morschhauser, F; Sloots, L; Zinzani, PL, 2007)
"Etoposide levels were determined by high-performance liquid chromatography (HPLC), and pharmacokinetic parameters were calculated with the TOPFIT computer program."2.73Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas. ( Ehninger, G; Friedrichsen, K; Haenel, M; Kroschinsky, FP; Mueller, J; Prondzinsky, R; Pursche, S; Schleyer, E, 2008)
"Prednisolone 40 mg/m(2) was administered daily for three 14-day periods during weeks 1-2, 5-6 and 9-10."2.72Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma. ( Aoki, S; Hirano, M; Kohori, M; Miura, I; Niitsu, N; Okamoto, M, 2006)
"Idarubicin is a 4-demethoxy-anthracycline analogue of daunorubicin that has proven activity in non-Hodgkin lymphoma, and has been reported to cause less cardiotoxicity."2.71Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. ( Burton, C; Cunningham, D; Hancock, B; Hoskin, P; Linch, D; Qian, W; Smith, P; Vaughan-Hudson, G, 2005)
"Rituximab, a chimeric monoclonal antibody, produces response rates of up to 73% in patients with previously untreated indolent non-Hodgkin's lymphoma (NHL), and has high activity when combined with chemotherapy."2.71Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma. ( Christodoulou, C; Dimopoulos, M; Economopoulos, T; Fountzilas, G; Hamilos, G; Kalantzis, D; Nicolaides, C; Papageorgiou, E; Pavlidis, N, 2003)
"Mitoxantrone is an anthracenedione, which is active in NHL and its toxicity profile may be more favorable than doxorubicin with respect to alopecia, mucositis and cardiotoxicity."2.71A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma. ( Angelopoulou, MK; Bourantas, KL; Christopoulos, G; Grigorakis, V; Kalmantis, T; Kokkinis, G; Korantzis, J; Michalis, E; Mihalakeas, I; Pangalis, GA; Papayiannis, A; Repousis, P; Roussou, P; Siakantaris, MP; Stamatellou, M; Stefanoudakis, E; Symeonidis, A; Vassilakopoulos, TP; Vrakidou, E, 2003)
"CHOP-14 with the addition of rhG-CSF is safe and practicable in a large multicentre setting in patients aged 18-75 years."2.71Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A, 2003)
" In this multicenter study, THP (pirarubicin)-COP (cyclophosphamide, vincristine, and prednisolone) was compared to two thirds dosage of full CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) regimen with regard to both adverse events and efficacy."2.71Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. ( Harada, M; Hotta, T; Kitamura, K; Masaoka, T; Masuda, M; Matsuda, T; Miura, AB; Miyazaki, T; Mizoguchi, H; Mori, M; Niho, Y; Saito, H; Shibata, A; Takaku, F, 2005)
"Epirubicin is an agent with a lower incidence of cardiotoxicity and myelotoxicity compared with doxorubicin; and it is active in patients with non-Hodgkin's lymphoma (NHL)."2.70Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study. ( Alici, S; Basaran, M; Bavbek, ES; Camlica, H; Dogan O, O; Eralp, Y; Onat, H; Sakar, B; Tas, F; Yaman, F, 2001)
" There were no toxic deaths."2.69Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation. ( Cavenagh, JD; Eden, AG; Hughes, A; Kelsey, SM; Lamont, A; McBride, NC; Mills, MJ; Newland, AC; Ward, MC, 1999)
" The administration of G-CSF at a dosage of 5 micrograms/kg/day for 11 doses following CHOP resulted in an overall net cost of $Can1257."2.68Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma. ( Altmayer, C; Dranitsaris, G; Quirt, I, 1997)
"However, leukocytopenia was observed in many patients despite combined use of G-CSF, suggesting the dose and administration method of THP should be studied further."2.68[Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma]. ( Nakayama, M; Niitsu, N; Umeda, M, 1997)
" The mean bioavailability was 14% for chlorambucil, 21% for phenylacetic acid mustard, and 22% for prednisolone, when given as prednimustine, compared to the administration of free compounds in stoichiometrically equivalent doses."2.67Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration. ( Loos, U; Malek, M; Musch, E; Riedel, E, 1991)
" However on multivariate analysis only the presence of bulky disease and of B symptoms were independent adverse factors for response and for survival."2.67EPIC: an effective low toxicity regimen for relapsing lymphoma. ( Ashley, S; Catovsky, D; Cunningham, D; Gore, ME; Hickish, T; Mansi, J; Nicolson, V; Roldan, A; Smith, IE, 1993)
"Epirubicin is an effective agent when used in combination chemotherapy in both low grade and high grade lymphoma with less toxicity than doxorubicin."2.66Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma. ( Al-Ismail, SA; Gough, J; Whittaker, JA, 1987)
"In the chronic lymphocytic leukemia group, 3/4 have had benefit."2.64Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087). ( Aungst, CW; Mittelman, A; Murphy, GP, 1975)
"Mitoxantrone has a broad anti-tumour activity including lymphoma with potentially less cardiotoxicity than doxorubicin, which may be of particular importance in elderly patients."2.44CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis). ( Ahlbom, A; Anders, A; Andersson, T; Björkholm, M; Eva, O; Magnus, B; Ösby, E; Tomas, A, 2008)
"Although pemphigus vulgaris is not a common disease of the oral cavity, its potential to cause severe or life-threatening disease is such that the general dentist must have an understanding of its pathophysiology, clinical presentation and management."2.43Blistering mucocutaneous diseases of the oral mucosa--a review: part 2. Pemphigus vulgaris. ( Daley, T; Darling, MR, 2006)
"Erythema nodosum is the most frequent clinicopathological variant of the panniculitides."2.42[Erythema nodosum association with malignant lymphoma]. ( Griniūte, R; Pileckyte, M, 2003)
"A 47 year old woman with a MALT lymphoma affecting the breast exclusively is reported."2.40[Primary MALT-type lymphoma of the breast]. ( Campo, E; Cervantes, F; Esteve, J; Montserrat, E; Rafel, M; Serra, A; Velasco, M, 1998)
"Although vomiting was not observed in the acute phase, nausea was seen in 22."1.48[Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)]. ( Hosono, N; Itoh, K; Matsuda, Y; Oiwa, K; Ookura, M; Tai, K; Ueda, T; Yamauchi, T, 2018)
"Neutropenia was documented in 20 dogs (57%): 12 grade I to II, 8 grade III to IV."1.48Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas. ( Amores-Fuster, I; Blackwood, L; Finotello, R; Harper, A; Killick, DR; Maddox, TW; Mason, SL; Tanis, JB, 2018)
"Histopathological subtypes consist of Burkitt's lymphoma (BL) in 32 (43."1.48Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan. ( Anwar, S; Faizan, M; Khan, S, 2018)
"Postoperative pyoderma gangrenosum has been most commonly reported from breast and visceral surgery."1.46[Pyoderma gangraenosum after implantation of a shoulder endoprothesis]. ( Anderl, W; Domej, MA; Heuberer, PR; Pauzenberger, L, 2017)
" This study aimed to assess the efficacy and toxicity of dose-adjusted CHOP alone or in combination with rituximab (R-CHOP) by examining the stem cell mobilization in NHL patients."1.42Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma. ( Gui, L; Han, X; He, X; Liu, P; Qin, Y; Shi, Y; Yang, J; Yang, S; Yao, J; Zhang, C; Zhang, S; Zhao, L; Zhou, P; Zhou, S, 2015)
"Treatment with amphotericin B(AMPH-B) and flucytosine(5-FC) was initiated as diagnosis of cryptococcus meningitis."1.37Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review. ( Ainoda, Y; Fujita, T; Hirai, Y; Mori, N; Motoji, T; Shiseki, M; Shoji, T; Teramura, M; Totsuka, K; Yoshinaga, K, 2011)
"Lentigines are characterized by brown macules developing due to increased proliferation of melanocytes in the dermoepidermal junction."1.36Generalized eruptive lentiginosis induced by chemotherapy. ( De, D; Dogra, S; Kanwar, AJ; Saikia, UN, 2010)
"She was eventually diagnosed as having acute myeloblastic leukemia (AML; M0) with non-Hodgkin lymphoma (NHL)."1.35Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma. ( Horikoshi, A; Hosokawa, Y; Iriyama, N; Ishizuka, H; Kitoh, T; Sawada, S; Shiraiwa, H; Takei, K; Uenogawa, K, 2009)
"Granulocytic sarcoma is an extramedullary tumor composed of immature granulocytic precursor cells."1.34Granulocytic sarcoma in the absence of acute myeloid leukemia: a case report. ( Adil, SN; Khalid, S; Vaziri, IA, 2007)
"BOOP was diagnosed and he responded well to oral prednisolone."1.33Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim. ( Allen, D; Burke, E; Drake, M; Elborn, S; Gleadhill, I; Kettle, P; Macartney, C; Magee, N; Noone, P, 2005)
"Gastrointestinal mucormycosis is a rare, often fatal, systemic infection found predominantly in immunocompromised patients."1.31Gastrointestinal mucormycosis complicated by arterio-enteric fistula in a patient with non-Hodgkin's lymphoma. ( Edmonson, R; Mir, N; Rashid, H; Yeghen, T, 2000)
"One cat, with lymphosarcoma limited to a single mandibular lymph node, was treated using surgery alone and was cured."1.31Therapy for Australian cats with lymphosarcoma. ( Canfield, PJ; Foster, SF; Gabor, LJ; Malik, R; McCorkell, BE, 2001)
"We describe two cases of interstitial lung disease in patients with non-Hodgkin's lymphoma who were treated with combination chemotherapy including mitozantrone."1.30Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy. ( Johnson, S; Nicholson, AG; Rule, S; Stone, R; Tighe, M; Tomlinson, J, 1999)
"Four years and 4 months later, refractory anemia with excess of blasts (RAEB) with dup(11) (q21q23) x 2 developed in the patient and progressed to acute myeloid leukemia (AML-M5b)."1.30[Therapy-related MDS/leukemia carrying dup(11) (q21q23) with MLL gene tandem duplication]. ( Eguchi, M; Eguchi-Ishimae, M; Imanaka, F; Kamada, N; Takimoto, Y, 1998)
"We treated three cases of interstitial pneumonitis (IP) in 26 elderly (> or = 65 years old) patients with non-Hodgkin's lymphoma (NHL) who received the same chemotherapeutic protocol including granulocyte colony-stimulating factor (G-CSF) administration."1.30Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma. ( Abe, T; Hasegawa, Y; Kamoshita, M; Kobayashi, T; Kojima, H; Nagasawa, T; Ninomiya, H; Ohtani, K, 1997)
"Pneumonitis is a well recognized side effect of this drug, but occurs at low doses in the treatment of NHL."1.30Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma. ( Bloor, AJ; Marcus, RE; Seale, JR, 1998)
"The history revealed an anaplastic anemia."1.29[Mycotic retrobulbar neuritis]. ( Kössling, S; Meier, P; Nenning, H; Penk, A, 1994)
"Chylothorax is an accumulation of thoracic lymph or chyle in the pleural cavity."1.29Intrapleural bleomycin in the treatment of chylothorax. ( Aasebø, U; Norum, J, 1994)
"Fever or/and clinical infection were observed in 4% and 14% of cycles."1.29Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte. ( Biron, P; Bordessoule, D; Coiffier, B; Gisselbrecht, C; Guerci, A; Herbrecht, R; Kerneis, Y; Lederlin, P; Reyes, F; Sebban, C; Tilly, H, 1996)
"In stage III and IV Hodgkin's disease, for example, an age-adjusted COPP regimen may be adopted."1.28[Treatment of elderly patients with hematological malignancies]. ( Mizoguchi, H; Saito, H, 1992)
"The survival of patients with diffuse lymphoma large cell type (DL) was better than those with other diffuse lymphomas."1.28[Combination chemotherapy (modified CHOP-Bleo) in non-Hodgkin's lymphoma]. ( Aotsuka, N; Asai, T; Endoh, N; Hirasawa, A; Hiruma, K; Igarashi, T; Nakamura, H; Oh, H; Wakita, H; Yoshida, S, 1990)
"The use of azathioprine in ulcerative colitis is unclear."1.28The role of azathioprine in the management of ulcerative colitis. ( Axon, AT; Burke, DA; Foster, PN; Johnston, D; Lobo, AJ, 1990)
" Combination of radiotherapy and chemotherapy can improve the survival rate, but the optimal dosage needs to be investigated further."1.28Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. ( Abe, M; Dodo, Y; Shibamoto, Y; Shima, N; Tsutsui, K; Yamabe, H, 1990)
"Seventeen patients with non-Hodgkin's lymphoma (NHL) and 2 patients with Hodgkin's disease (HD) were treated by combination chemotherapy (COPP or CHOP), and then received 300 X 10(4) U of alpha-IFN daily for 14 days."1.27[A preliminary study of chemo-interferon therapy in malignant lymphoma]. ( Fukutani, H; Takeyama, H; Watanabe, E; Yano, K, 1987)
"15 patients with malignant lymphomas (stage III B or IV) who had become resistant to previous combination chemotherapy were treated with DTIC."1.26Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations. ( Donner, L; Klener, P, 1977)
"For patients with lymphosarcoma the average duration of complete remission was 26."1.26[Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)]. ( Hiller, E; Schmülling, RM; Tigges, FJ; Waller, HD; Wilms, K, 1977)
"A case of lymphosarcoma of the heart in a 10-year-old boy is presented."1.25Mediastinal lymphosarcoma simulating pericarditis. ( Berg, M; Eriksson, A; Wilander, E, 1975)
"Necropsy revealed a reticulum cell sarcoma-microglioma of the brain."1.25Cerebral reticulum cell sarcoma after multiple renal transplants. ( Barnett, LB; Schwartz, E, 1974)

Research

Studies (478)

TimeframeStudies, this research(%)All Research%
pre-1990110 (23.01)18.7374
1990's173 (36.19)18.2507
2000's154 (32.22)29.6817
2010's39 (8.16)24.3611
2020's2 (0.42)2.80

Authors

AuthorsStudies
Ikeda, T1
Fujiwara, SI1
Nakajima, H1
Kawaguchi, SI1
Toda, Y1
Ito, S1
Ochi, S1
Nagayama, T1
Mashima, K1
Umino, K1
Minakata, D1
Nakano, H1
Morita, K2
Yamasaki, R1
Kawasaki, Y1
Ashizawa, M1
Yamamoto, C1
Hatano, K1
Sato, K1
Oh, I1
Ohmine, K1
Muroi, K2
Kanda, Y1
Maggen, C1
Dierickx, D1
Cardonick, E1
Mhallem Gziri, M1
Cabrera-Garcia, A1
Shmakov, RG1
Avivi, I1
Masturzo, B1
Duvekot, JJ1
Ottevanger, PB1
O'Laughlin, A1
Polushkina, E1
Van Calsteren, K1
Woei-A-Jin, FJSH1
Amant, F1
Domej, MA1
Pauzenberger, L1
Heuberer, PR1
Anderl, W1
Faizan, M1
Anwar, S1
Khan, S1
Oiwa, K1
Hosono, N1
Itoh, K6
Ookura, M1
Matsuda, Y1
Tai, K1
Ueda, T1
Yamauchi, T1
Tanis, JB1
Mason, SL1
Maddox, TW1
Blackwood, L1
Killick, DR1
Amores-Fuster, I1
Harper, A1
Finotello, R1
Hagemeister, F2
Rodriguez, MA2
Deitcher, SR1
Younes, A2
Fayad, L1
Goy, A1
Dang, NH1
Forman, A1
McLaughlin, P3
Medeiros, LJ1
Pro, B1
Romaguera, J1
Samaniego, F1
Silverman, JA1
Sarris, A1
Cabanillas, F2
Kiratli, H1
Tarlan, B1
Uzun, S1
Tanas, Ö1
Uner, A1
Maie, K1
Okoshi, Y1
Takaiwa, N1
Kurita, N1
Hasegawa, Y2
Homma, M1
Ishii, K1
Kohda, Y1
Chiba, S1
Limmer, S1
Eberle, N1
Nerschbach, V1
Nolte, I1
Betz, D1
Hiraishi, Y1
Iikura, M1
Kogure, Y1
Hirashima, J1
Izumi, S1
Sugiyama, H1
Corradini, P1
Marchetti, M1
Barosi, G1
Billio, A1
Gallamini, A1
Pileri, S2
Pimpinelli, N1
Rossi, G2
Zinzani, PL4
Tura, S3
Ahmad, AK1
Hui, P1
Litkouhi, B1
Azodi, M1
Rutherford, T1
McCarthy, S1
Xu, ML1
Schwartz, PE1
Ratner, E1
Olivier, G1
Clavert, A1
Lacotte-Thierry, L1
Gardembas, M1
Escoffre-Barbe, M1
Brion, A1
Cumin, I1
Legouffe, E1
Solal-Celigny, P1
Chabin, M1
Ingrand, P1
Colombat, P2
Delwail, V2
Knutson, SK1
Warholic, NM1
Johnston, LD1
Klaus, CR1
Wigle, TJ1
Iwanowicz, D1
Littlefield, BA1
Porter-Scott, M1
Smith, JJ1
Moyer, MP1
Copeland, RA1
Pollock, RM1
Kuntz, KW1
Raimondi, A1
Keilhack, H1
Tseng, YD1
Chen, YH1
Catalano, PJ1
Ng, A1
Curran, K1
Thamm, DH1
Shi, Y1
Zhou, P1
Han, X1
He, X1
Zhou, S1
Liu, P1
Yang, J1
Zhang, C1
Gui, L1
Qin, Y1
Yang, S1
Zhao, L1
Yao, J1
Zhang, S1
Elting, LS1
Xu, Y1
Chavez-MacGregor, M1
Giordano, SH1
Gupta, A1
Tse, L1
Vranovsky, A1
Ladicka, M1
Lakota, J1
Jonathan, F1
Fagnoni, P1
Milpied, N2
Limat, S1
Deconinck, E2
Nerich, V1
Foussard, C1
Harousseau, JL1
Woronoff-Lemsi, MC1
Koo, YX1
Tan, DS1
Tan, BH1
Quek, R1
Tao, M1
Lim, ST1
Kabiri, el H1
Kabiri, M1
Doghmi, K1
Sharma, R1
Cunningham, D6
Smith, P5
Robertson, G1
Dent, O1
Clarke, SJ1
Nishigori, K1
Yamamoto, T2
Yokozeki, H1
Hainsworth, JD2
Spigel, DR1
Markus, TM1
Shipley, D1
Thompson, D1
Rotman, R1
Dannaher, C1
Greco, FA2
Chaiwun, B1
Sukhamwang, N1
Ya-In, C1
Shuangshoti, S1
Kondo, M2
Kitada, N1
Kobayashi, M1
Morita, S1
Yoshioka, M1
Tsuji, T1
Mori, A2
Okamoto, T3
Watari, M1
Fridrik, MA3
Hausmaninger, H2
Lang, A1
Drach, J2
Krieger, O1
Geissler, D1
Michlmayr, G1
Ulsperger, E1
Chott, A3
Oberaigner, W1
Greil, R1
Dincol, D1
Buyukcelik, A1
Dogan, M1
Akbulut, H1
Samur, M1
Demirkazik, A1
Senler, FC1
Onur, H1
Icli, F1
Horikoshi, A1
Takei, K2
Iriyama, N1
Uenogawa, K1
Ishizuka, H1
Shiraiwa, H1
Hosokawa, Y1
Sawada, S1
Kitoh, T1
Katsuya, H1
Suzumiya, J3
Sasaki, H1
Ishitsuka, K1
Shibata, T1
Takamatsu, Y1
Tamura, K3
Lan, MX1
Zhen, ZX1
Ming, WH1
De, D1
Dogra, S1
Kanwar, AJ1
Saikia, UN1
Qiao, W1
Zhao, J1
Wang, C1
Wang, T1
Xing, Y1
Hoffmann, M2
Schirmer, MA1
Tzvetkov, MV1
Kreuz, M1
Ziepert, M2
Wojnowski, L1
Kube, D1
Pfreundschuh, M8
Trümper, L6
Loeffler, M8
Brockmöller, J1
Cunningham, S1
Muneer, S1
Ranganathan, A1
Shrader, M1
Laatiri, MA1
Elloumi, M1
Ali, ZB1
Ben Othmen, T1
Msadek, F1
Toumi, N1
Bouaouina, N1
Daoud, J1
Maalej, M1
Ghannem, H1
Meddeb, B1
Kiewe, P1
Thiel, E3
Demirkaya, M1
Sevinir, B1
Ozdemir, O1
Nazlioğlu, HO1
Okan, M1
De Moerloose, B1
Suciu, S1
Bertrand, Y1
Mazingue, F1
Robert, A1
Uyttebroeck, A1
Yakouben, K1
Ferster, A1
Margueritte, G1
Lutz, P1
Munzer, M1
Sirvent, N1
Norton, L2
Boutard, P1
Plantaz, D1
Millot, F1
Philippet, P1
Baila, L2
Benoit, Y1
Otten, J1
Cronin, PA1
Myers, E1
Redmond, HP1
O'Reilly, S1
Kirwan, WO1
Shamsian, BS1
Goudarzipour, K1
Alavi, S1
Jadali, F1
Gharib, A1
Aghakhani, R1
Arzanian, MT1
Rezaei, N1
Lee, SM1
Cheng, B1
Cheung, YK1
Aurer, I1
Eghbali, H1
Raemaekers, J1
Khaled, HM1
Fortpied, C1
van der Maazen, RW1
Haioun, C6
Salar, A1
Pettengell, R3
Johnsen, HE1
Duehrsen, U2
Rossi, FG2
Verhoef, G3
Schwenkglenks, M2
Jaeger, U1
Hamilton, L1
Pujol, B2
Lugtenburg, PJ2
Hirai, Y1
Ainoda, Y1
Shoji, T1
Fujita, T1
Yoshinaga, K1
Shiseki, M1
Mori, N1
Teramura, M1
Totsuka, K1
Motoji, T1
Schmitz, N6
Zeynalova, S3
Glass, B2
Kaiser, U5
Cavallin-Stahl, E2
Wolf, M1
Haenel, M2
Truemper, L2
Fløisand, Y1
Brinch, L1
Gedde-Dahl, T1
Tjønnfjord, GE1
Dybedal, I1
Holte, H1
Heldal, D1
Torfoss, D1
Aurlien, E1
Lauritzsen, GF1
Fosså, A1
Lehne, G1
Baggerød, E1
Kvalheim, G1
Egeland, T1
Bishop, MR1
Fowler, DH1
Kolstad, A1
Mizuno, R1
Fujimoto, S1
Okamoto, Y1
Silvestre, AS1
Wheeler, T1
Zyrina, GV1
Vose, JM2
Weisenburger, DD1
Lynch, JC1
Bierman, PJ1
Chan, JC1
Bast, M1
Aoun, P1
Bociek, G1
Greiner, T1
Armitage, JO3
Rummel, MJ1
Mitrou, PS1
Hoelzer, D1
Portlock, CS1
Balzarotti, M2
Spina, M1
Sarina, B1
Magagnoli, M1
Castagna, L1
Milan, I1
Ripa, C1
Latteri, F2
Bernardi, D1
Bertuzzi, A1
Nozza, A1
Roncalli, M1
Morenghi, E1
Tirelli, U2
Santoro, A2
Ohtsu, T2
Fukuda, H2
Sasaki, Y1
Ogura, M4
Morishima, Y3
Chou, T1
Aikawa, K1
Uike, N1
Mizorogi, F1
Ohno, T1
Ikeda, S2
Sai, T2
Taniwaki, M2
Kawano, F2
Niimi, M1
Hotta, T5
Shimoyama, M4
Tobinai, K4
Spaepen, K1
Stroobants, S1
Dupont, P1
Vandenberghe, P1
Thomas, J1
de Groot, T1
Balzarini, J1
De Wolf-Peeters, C1
Mortelmans, L1
van Agthoven, M1
Faber, LM1
Uyl-de Groot, CA1
Sonneveld, P5
Verdonck, LF3
Willemze, R1
Kluin-Nelemans, JC1
Löwenberg, B2
Huijgens, PC2
Fisher, RI3
Uebelacker, I1
Abel, U1
Birkmann, J2
Schmalenberg, H2
Karakas, T1
Metzner, B2
Hossfeld, DK1
Bischoff, HG1
Franke, A2
Reiser, M2
Müller, P1
Mantovani, L1
Grundeis, M1
Rothmann, F1
von Seydewitz, CU1
Mesters, RM1
Steinhauer, EU2
Krahl, D1
Schumacher, K1
Kneba, M1
Baudis, M2
Pfab, R5
Köppler, H4
Parwaresch, R1
Havemann, K3
Franco, A1
Jiménez, L1
Aranda, I1
Alvarez, L1
González, M1
Rocamora, N1
Olivares, J1
Stewart, AJ1
Southcott, BM1
Coiffier, B9
Mottl, H1
Bajciova, V1
Nemec, J1
Al Shemmari, S1
Al Awadi, S1
Shimizu, J1
Ishida, Y1
Takehara, A1
Kinoshita, T4
Tatsuzawa, Y1
Kawaura, Y1
Matsumoto, I1
Imai, M1
Bessell, EM3
Burton, A1
Haynes, AP1
Glaholm, J1
Child, JA2
Cullen, MH2
Davies, JM2
Smith, GM1
Ellis, IO2
Jack, A3
Jones, EL1
Herold, M2
Dölken, G1
Fiedler, F1
Freund, M1
Helbig, W1
Pasold, R1
Economopoulos, T3
Fountzilas, G3
Pavlidis, N3
Kalantzis, D1
Papageorgiou, E1
Christodoulou, C1
Hamilos, G1
Nicolaides, C2
Dimopoulos, M1
Pangalis, GA1
Vassilakopoulos, TP1
Michalis, E1
Roussou, P1
Vrakidou, E1
Repousis, P1
Angelopoulou, MK1
Siakantaris, MP1
Korantzis, J1
Symeonidis, A1
Grigorakis, V1
Stefanoudakis, E1
Stamatellou, M1
Bourantas, KL1
Kalmantis, T1
Christopoulos, G1
Kokkinis, G1
Mihalakeas, I1
Papayiannis, A1
Pileckyte, M1
Griniūte, R1
Wunderlich, A1
Kloess, M3
Rudolph, C1
Bittner, S1
Schmits, R2
Daum, S1
Ullrich, R1
Heise, W1
Dederke, B1
Foss, HD1
Stein, H1
Zeitz, M1
Riecken, EO1
Lee, JJ1
Nam, CE1
Cho, SH1
Park, KS1
Chung, IJ1
Kim, HJ2
Zhang, DS1
Jiang, WQ2
Li, S1
Zhang, XS1
Mao, H1
Chen, XQ1
Li, YH1
Zhan, J1
Wang, FH1
López-Duarte, M1
Insunza, A1
Conde, E1
Iriondo, A1
Mazorra, F1
Zubizarreta, A1
Mead, G1
Woodcock, J1
Young, C1
STACHER, A1
BOEHNEL, J1
KYLE, RA1
McPARLAND, CE1
DAMESHEK, W1
BENEDETTI, A1
FUSARO, A1
POLI, D1
GRODEN, BM1
DUNNIGAN, MG1
ARAPAKIS, G1
JORDANOGLOU, J1
AOKI, Y1
KAWABE, A1
MASHIMA, T1
OGURO, C1
ARDOUIN, AP1
LIBERTI, R1
PLATTNER, I1
SCHREK, R1
MURRAY, PJ1
SLADDEN, RA1
Lyman, GH3
Delgado, DJ3
Mandigers, CM1
Meijerink, JP1
Dekker, AW1
Schattenberg, AV1
Raemaekers, JM1
Tsurumi, H2
Yamada, T2
Sawada, M2
Kasahara, S2
Kanemura, N2
Kojima, Y2
Fukuno, K1
Hara, T2
Saio, M1
Takahashi, T2
Oyama, M2
Ozawa, K1
Takami, T1
Moriwaki, H2
Mantzios, G1
Tsirigotis, P1
Veliou, F1
Boutsikakis, I1
Petraki, L1
Kolovos, J1
Papageorgiou, S1
Robos, Y1
Morrison, VA3
Dale, DC2
Crawford, J2
Fridman, M2
Froehner, M1
Haase, M1
Hakenberg, OW1
Wirth, MP1
Sayarlioglu, M1
Bayram, I1
Sayarlioglu, H1
Erkoc, R1
Yamamura, R1
Yamane, T3
Aoyama, Y1
Nakamae, H1
Hasegawa, T1
Ohta, K1
Nakao, Y1
Ohta, T1
Mugitani, A1
Hino, M1
DiBiase, SJ1
Grigsby, PW1
Guo, C1
Lin, HS1
Wasserman, TH1
Gergely, L1
Aleksza, M1
Váróczy, L1
Ponyi, A1
Sipka, S1
Illés, A1
Szegedi, G1
Jung, CK1
Park, JS1
Lee, EJ1
Kim, SH1
Kwon, HC1
Kim, JS1
Roh, MS1
Yoon, SK1
Kim, KH1
Han, JY1
Tomandl, J1
Palyza, V1
Tallová, J1
Drbal, J1
Miller, TP1
Horning, SJ1
Weller, E1
Kim, K1
Earle, JD2
O'Connell, MJ1
Habermann, TM1
Glick, JH1
Jullien, V1
Perrin, C1
Peyrade, F1
Lemoigne, F1
Chichmanian, RM1
Blaive, B1
Osby, E2
Askling, J1
Landgren, O1
Dickman, PW1
Ekbom, A1
Björkholm, M3
Mounier, N2
Gisselbrecht, C7
Brière, J2
Feugier, P1
Offner, F1
Recher, C1
Stamatoullas, A1
Morschhauser, F2
Macro, M1
Thieblemont, C1
Sonet, A1
Fabiani, B1
Reyes, F4
Sinha, A1
Velangi, S1
Natarajan, S1
Coutinho, F2
Manhani, AR2
Velasquez, WS1
Del Giglio, A2
Friedberg, J1
Hidaka, S1
Takechi, S1
Nonaka, S1
Joko, K1
Vigliotti, ML1
Dell'Olio, M1
La Sala, A1
Romano, G1
Tartarone, A1
Mele, G1
Musto, C1
Carella, AM1
Di Renzo, N1
Grigg, A3
Czuczman, MS3
Weaver, R1
Alkuzweny, B1
Berlfein, J1
Grillo-López, AJ1
Constantinou, J1
Nitkunan, T1
Al-Izzi, M1
McNicholas, TA1
Alexandrescu, DT1
Dutcher, JP1
O'Boyle, K1
Albulak, M1
Oiseth, S1
Wiernik, PH1
Rossum, MM1
Verhaegen, NT1
Jonkman, MF1
Mackenzie, MA1
Koster, A1
Van Der Valk, PG1
Span, LF1
Kobayashi, T3
Ishizuka, N1
Tomonaga, M1
Ohno, Y2
Kasai, M1
Mikuni, C3
Toki, H2
Sano, M3
Masaki, Y1
Matsuno, Y2
Takenaka, T2
Shirakawa, S2
Othieno-Abinya, NA1
Abwao, HO1
Maina, JM1
Nyabola, LO1
Opiyo, A1
Njuguna, E1
Ndege, P1
Musibi, A1
Hatta, T1
Ohnishi, N1
Kusaba, T1
Tanda, S1
Narumiya, H1
Tamagaki, K1
Kameyama, H1
Yamada, K1
Sasaki, S3
Takeda, K1
Wöhrer, S1
Raderer, M1
Kaufmann, H1
Hejna, M1
Zielinski, CC1
Gershanovich, ML1
Tikhonova, VV1
Mori, M1
Kitamura, K2
Masuda, M1
Miyazaki, T1
Miura, AB3
Mizoguchi, H2
Shibata, A1
Saito, H2
Matsuda, T6
Masaoka, T5
Harada, M1
Niho, Y1
Takaku, F3
Fulignati, C1
Pantaleo, P1
Cipriani, G1
Turrini, M1
Nicastro, R1
Mazzanti, R1
Neri, B1
Bernard, M1
Cartron, G1
Rachieru, P1
LeMevel, A1
Branger, B1
Le Maignan, C1
Berthou, C1
Ghandour, C1
Cassasus, P1
Celigny, PS1
Guyotat, D1
Lamy, T1
Desablens, B1
Jabbour, E1
Peslin, N1
Arnaud, P1
Ferme, C2
Carde, P1
Vantelon, JM1
Bocaccio, C1
Bourhis, JH2
Koscielny, S1
Ribrag, V2
Hsiao, HH1
Sashida, G1
Ito, Y2
Tachino, M1
Beppu, H1
Ohyashiki, K1
Burton, C2
Vaughan-Hudson, G1
Qian, W2
Hoskin, P3
Hancock, B3
Linch, D3
Macartney, C1
Burke, E1
Elborn, S1
Magee, N1
Noone, P1
Gleadhill, I1
Allen, D1
Kettle, P1
Drake, M1
Kambayashi, T1
Ono, N1
Terada, Y1
Taga, T2
Sakaue, Y1
Anzai, Y1
Takeuchi, Y1
Ohta, S1
Mizoroki, F1
Hirose, Y1
Nakata, M1
Uozumi, K1
Sawada, K2
Fukuhara, S2
Nasu, K2
Togawa, A1
Kikuchi, M5
Motomura, S5
Hashimoto, C1
Kodama, F5
Maruta, A4
Sakai, R3
Fujita, H3
Tomita, N3
Fujisawa, S3
Harano, H3
Koharazawa, H1
Fujimaki, K1
Kanamori, H5
Ishigatsubo, Y2
Darling, MR1
Daley, T1
Milligan, D2
Dyer, MJ1
Mouncey, P1
MacLennan, K2
Webb, A1
Yoshikawa, T1
Goto, N1
Tomita, E1
Kagami, Y2
Watanabe, T1
Igarashi, T2
Ohashi, Y1
Mori, S1
Terauchi, T1
Herishanu, Y1
Polliack, A1
Leider-Trejo, L1
Grieff, Y1
Metser, U1
Naparstek, E1
Adenipekun, A1
Abudus-Salam, A1
Elumele, TN1
Shikama, N2
Oguchi, M2
Isobe, K1
Nakamura, K3
Tamaki, Y1
Hasegawa, M1
Kodaira, T1
Niitsu, N3
Okamoto, M3
Kohori, M1
Aoki, S1
Miura, I1
Hirano, M4
Vassallo, E1
Di Noto, L1
Palmeri, L1
Vaglica, M1
Pancera, G1
Palmeri, S1
Boehme, V1
Sawicka-Zukowska, M1
Kajdas, L1
Muszynska-Roslan, K1
Krawczuk-Rybak, M1
Sonta-Jakimczyk, D1
Szczepanski, T1
Tanaka, PY1
Pracchia, LF1
Calore, EE1
Dantas, AA1
Sugimoto, T3
Matano, S4
Nishijima, H1
Kakuta, K1
Inamura, K1
Okamura, T1
Munemoto, S1
Satoh, S1
Maciel, JF1
de Lourdes Chauffaille, M1
Inaoka, RJ1
Colleoni, GW2
Yamamoto, M1
Rund, D1
Burgess, M1
Sloots, L1
Bouafia, F1
Dumontet, C3
Khalid, S1
Adil, SN1
Vaziri, IA1
Kroschinsky, FP1
Friedrichsen, K1
Mueller, J1
Pursche, S1
Prondzinsky, R1
Ehninger, G1
Schleyer, E1
Busse, A1
Hütter, G1
Siehl, JM1
Schmittel, A1
Keilholz, U1
Li, ZM1
Zhu, ZY1
Zhu, XF1
Zhou, JM1
Liu, ZC1
Yang, DJ1
Guang, ZZ1
Widmann, T1
Kneer, H1
König, J1
Herrmann, M1
Ohye, H1
Fukata, S1
Hirokawa, M1
Navarro, JT1
Ribera, JM1
Oriol, A1
Xicoy, B1
Mate, JL1
Sirera, G1
Lloveras, N1
Millá, F1
Feliu, E1
Zwick, C2
Dührsen, U1
Pflüger, KH4
Vrieling, T1
Mesters, R1
Mergenthaler, HG1
Einsele, H1
Bentz, M3
Lengfelder, E1
Rübe, C2
Cheng, MH1
Chao, HT1
Wang, PH1
Lim, KH1
Chiou, TY1
Lin, CJ1
Hsieh, RK2
Hohloch, K1
Mohren, M1
Liersch, R1
Graeven, U1
Wruck, U1
Hasenclever, D1
Basecke, J1
Podleschny, M1
Becker, A1
Seiffert, E1
Schwiers, I1
Schwiers, R1
Haase, D1
Griesinger, F1
Magnus, B1
Andersson, T1
Tomas, A1
Ahlbom, A1
Anders, A1
Eva, O1
Mitchell, PL1
Marlton, P1
Seymour, JF1
Hertzberg, M1
Enno, A1
Herrmann, R1
Bond, R1
Arthur, C1
Hohenwallner, W1
Höche, D1
Wutke, K1
Rüdiger, KD1
Anger, G1
Kästner, R1
Borisov, VI1
Korobkova, LI1
Vashakmadze, LA1
Frank, GA1
Abdyldaev, RA1
Kruglova, GV7
Ideström, K1
Kimby, E2
Mellstedt, H1
Engstedt, L1
Gahrton, G1
Johansson, B1
Killander, D1
Robérts, KH1
Stalfelt, AM1
Udén, AM1
Wadman, B1
Wählby, S2
Kondrat'eva, NA2
Lorie, IuI3
Vorob'ev, AI1
Brilliant, MD1
Blackledge, G1
Bush, H1
Chang, J1
Crowther, D3
Deakin, DP2
Dodge, OG1
Garrett, JV1
Palmer, M1
Pearson, D1
Scarffe, JH3
Todd, ID1
Wilkinson, PM2
Makhonova, LA1
Maiakova, SA1
Vialushkin, BIa1
McAdam, B1
Smith, T1
Love, WC1
Murphy, M1
Daly, PA1
Inoue, T2
Fujiyama, Y1
Kitoh, K1
Niwakawa, M1
Andoh, A1
Hodohara, K1
Bamba, T1
Hosoda, S1
Cooper, IA2
Wolf, MM1
Robertson, TI1
Fox, RM1
Matthews, JP2
Stone, JM1
Ding, JC2
Dart, G1
Matthews, J1
Firkin, FC1
Delmer, A1
Bauduer, F1
Ruskoné-Fourmestraux, A1
Ajchenbaum-Cymbalista, F1
Delmas-Marsalet, B1
Rio, B1
Marie, JP1
Zittoun, R1
Morel, P4
Dupriez, B2
Herbrecht, R7
Bastion, Y2
Tilly, H6
Delannoy, A1
Nouvel, C2
Bouabdallah, K1
Baumelou, E1
Tanabe, J4
Matsuzaki, M3
Mohri, H1
Okubo, T2
Lishner, M1
Slingerland, J1
Theresa, C1
Sutcliffe, SB1
Jackson, GH1
Lennard, AL2
Taylor, PR2
Carey, P1
Angus, B2
Lucraft, H1
Evans, RG2
Proctor, SJ2
Tanosaki, R1
Okamoto, S1
Akatsuka, N1
Ishida, A1
Michikawa, N1
Masuda, Y1
Uchida, H1
Murata, M1
Kizaki, M1
Ikeda, Y1
Lepage, E3
Bosly, A4
D'Agay, MF1
Norum, J1
Aasebø, U1
O'Neill, BP1
O'Fallon, JR1
Colgan, JP1
Brown, LD1
Krigel, RL1
Brada, M1
Dreger, P1
Klöss, M2
Petersen, B1
Haferlach, T1
Löffler, H1
de Ridder, M1
van der Lelie, H1
Nieuwenhuis, K2
Schouten, H1
Mulder, A1
van Reijswoud, I1
Hop, W2
Cabanillas, FC1
Velasquez, W2
Hagemeister, FB1
Swan, F2
Romaguera, JE1
Sharma, UK1
Jha, V1
Joshi, K1
Ahmed, S1
Sakhuja, V1
Bezwoda, W1
Rastogi, RB1
Erazo Valla, A1
Diaz-Maqueo, JC1
Pavlovsky, S2
Morioka, H1
Resegotti, L1
Rueckle, H1
Somoza, N2
Moreno-Nogueira, JA1
Taillan, B1
Garnier, G1
Schneider, S1
Pesce, A1
Fuzibet, JG2
Dujardin, P1
Cuthbert, RJ1
Craig, JI1
Ludlam, CA1
Ang, PT2
Soh, LT2
Sng, I2
Chua, EJ2
Ong, YW2
Schofield, K1
Morris, D1
Klapper, P1
Waits, TM1
Greer, JP1
Kohda, K1
Tsuji, A1
Takayanagi, N1
Takeda, M1
Hayashi, S1
Takimoto, R1
Fujisaki, Y1
Tsuji, Y1
Ezoe, A1
Nakazawa, O1
Sebban, C3
Takeshima, M1
Nakamura, S7
Mochizuki, Y1
Hattori, N1
Kaya, H1
Otake, S1
Okabe, Y1
Okumura, H1
Yoshida, T5
Evans, TR1
Mansi, JL1
Bevan, DH1
Dalgleish, AG1
Harmer, CL1
Shimizu, H1
Takaue, Y1
Utsumi, J1
Takeda, T1
Fujimoto, T3
Reiter, A2
Bernard, T1
Johnson, SA1
Prentice, AG2
Jones, L1
Phillips, MJ1
Newland, AC5
Pendleton, N1
Green, JA3
Cowley, NC1
Neill, SM1
Staughton, RC1
Obrist, R1
Coutts, A1
Fletcher, J2
Toghill, PJ1
Moloney, AJ1
Hulman, G1
Jenkins, D1
Chan-Lam, D1
Copplestone, JA1
Weston, M1
Williams, M1
Hutton, CW1
Nenning, H1
Meier, P1
Penk, A1
Kössling, S1
Mulder, AH1
Michiels, JJ2
Blijham, G1
van de Lelie, J1
Raemakers, JW1
van der Heul, C1
Eschenbach, I3
Zeller, W2
Holle, R1
Steinhauer, UE1
Gropp, C2
Oehl, S2
Bezwoda, WR1
Bezwoda, MA1
Seymour, L1
Dansey, R1
Ariad, S1
Sampi, K4
Takagi, T5
Morii, K1
Hattori, M4
Matsuura, Y1
Nakamura, H2
Kogure, K1
Fukazawa, M1
Okuyama, Y1
Kawano, E1
Ishii, A1
Nishimura, M1
Hashimoto, S1
Oh, H2
Doi, M1
Hisada, Y1
Namba, R1
Nakata, Y1
Saika, Y1
Shimizu, T1
Sueyoshi, K1
Kawai, T1
Narabayashi, I1
Hickish, T1
Roldan, A1
Mansi, J1
Ashley, S1
Nicolson, V1
Gore, ME1
Catovsky, D1
Smith, IE1
Okamoto, R1
Tamura, T1
Murata, T1
Hashimoto, Y1
Yokoi, M1
Nagai, T1
Hirabayashi, M1
Okamura, A1
Tatsumi, E1
Nishikori, M1
Garrett, TJ1
Chadburn, A1
Barr, ML1
Drusin, RE1
Chen, JM1
Schulman, LL1
Smith, CR1
Reison, DS1
Rose, EA1
Michler, RE1
Sweetenham, JW1
McKendrick, JJ1
Mead, GM1
Whitehouse, JM1
Toogood, IR1
Tiedemann, K1
Stevens, M1
Smith, PJ1
Chisesi, T2
Cajozzo, A1
Leone, G2
Papa, G2
Gentilini, P1
Aitini, E1
Mandelli, F2
Linkesch, W1
Stöger, M1
Sill, H1
Neubauer, M1
Seewann, HL1
Klocker, J1
Haidinger, R1
Schiller, L1
Pont, J1
Raudaschl, G1
Falk, M1
Radaszkiewicz, T1
Ferreri, AJ1
Reni, M1
Bolognesi, A1
Verusio, C1
Villa, E1
Silingardi, V1
Federico, M2
Cavanna, L2
Avanzini, P2
Gobbi, PG2
Lombardo, M2
Carotenuto, M2
Frassoldati, A1
Pieresca, C1
Vallisa, D1
Phillips, JK1
Sherlaw-Johnson, C1
Clough, JV1
Parry, H1
Nash, JR2
Cawley, JC1
Kobayashi, K5
Misaki, T1
Landys, KE2
Berg, GE1
Torgerson, JS1
Klingenstierna, HA1
Ridell, BS1
Johansson, BR1
Radford, JA1
Morgenstern, GR1
Harris, M2
Woll, PJ1
Ryder, D1
Linch, DC2
Vaughan Hudson, B1
Hancock, BW2
Hoskin, PJ3
Cunningham, DC2
Milligan, DW1
Stevenson, PA2
Wood, JK2
MacLennan, KA2
Anderson, L1
Gregory, WM2
Vaughan Hudson, G1
Sasai, K1
Yamabe, H2
Haga, H1
Tsutsui, K2
Dodo, Y2
Ishigaki, T1
Shibamoto, Y2
Abe, M3
Pettelot, G1
Gibelin, P1
Blanc, P1
Hoffman, P1
Ferrari, E1
Baudouy, M1
Morand, P1
Pääkkö, E1
Vainionpää, L1
Pyhtinen, J1
Lanning, M1
Brault, P1
Gilles, E1
Munck, JN2
Pico, JL1
Hayat, M1
Korobko, VB1
Chernyĭ, VA1
Valetskiĭ, VL1
Rozumiĭ, DA1
Gunina, LM1
Finogenova, IA2
Izumi, T1
Ohtsuki, T1
Ohya, K1
Ogawa, Y1
Yoshida, M4
Imagawa, S1
Hatake, K1
Kuriki, K1
Saito, K1
Miura, Y1
Maeda, N1
Nishizaki, S1
Furubayashi, T1
Sano, F2
Koike, M2
Ishibashi, M1
Tuji, K1
Katoh, M2
Hasegawa, S2
Maeba, T1
Takahashi, M2
Ohwada, S1
Ishida, M1
Burney, IA1
Malik, IA1
Taguchi, J2
Fukawa, H2
Mouri, H1
Gupta, NM1
Goenka, MK1
Jindal, A1
Behera, A1
Vaiphei, K1
Fahlenkamp, D1
Reinke, P1
Kirchner, S1
Schnorr, D1
Lindeke, A1
Loening, SA1
Grzelec, H1
Fryze, C1
Nowacki, P1
Zdziarska, B2
Laurencet, FM1
Zulian, GB1
Dietrich, PY2
Anchisi, S1
Mermillod, B1
Alberto, P1
Guerci, A1
Lederlin, P3
Bordessoule, D2
Kerneis, Y1
Biron, P1
Nakayama, M3
Umeda, M1
Newell, M1
Goldstein, D1
Milliken, S1
Lewis, C1
Hoy, J1
Thomson, B1
Cooper, D1
Izuno, I1
Gomi, K1
Sone, S1
Ramesh, V1
Tanwar, RK1
Kaushal, R1
Rath, GK1
Vaid, A1
Pathak, V1
Choubey, RP1
Kawasaki, G1
Nakai, M1
Mizuno, A1
Nakamura, T3
Okabe, H1
Kutluk, MT1
Hazar, V1
Akyüz, C1
Varan, A1
Büyükpamukçu, M1
Uehara, S1
Omagari, J1
Kunitake, N1
Jingu, K1
Masuda, K1
Kamieńska, E1
Luraschi, A1
Saglietti, G1
Ferrari, V1
Fedeli, P1
Ripamonti, G1
Gioria, A1
Bersi, M1
Ninomiya, H1
Kamoshita, M1
Ohtani, K1
Kojima, H2
Nagasawa, T1
Abe, T2
Hovgaard, DJ1
Stahl Skov, P1
Nissen, NI1
Blay, JY1
Divine, M1
Brice, P2
Blanc, M1
Salles, B1
Cameron, DA1
White, JM1
Prescott, RJ1
Leonard, RC1
Cook, MK1
Dawes, PJ1
Dawson, AA2
Galloway, MJ1
Harris, AL1
Heppleston, A1
Horne, CH1
Krajewski, AS1
Lessells, AM1
Lucraft, HH1
MacGillivray, JB1
Mackie, MJ1
Parker, AC1
Roberts, JT1
Thompson, WD1
Maruyama, K1
Sasako, M1
Sano, T1
Katai, H1
McNeil, C1
Geit, M1
Wahl, G1
Ehrengruber, A1
Simma, R1
Höpfel, I1
Bettelheim, P1
Leisch, F1
Chapman, R1
Szer, J1
Bos, GM1
van Putten, WL1
van der Holt, B1
van den Bent, M1
Hagenbeek, A1
Tsurusawa, M3
Yamamoto, Y2
Katano, N3
Hirota, T2
Miyawaki, T2
Yanase, T2
Koizumi, S3
Utumi, J1
Asami, K3
Tanaka, A2
Mugisima, H2
Hatae, Y2
Sekine, I2
Tsuchiya, T1
Yamamura, Y2
Iwai, A3
Kono, Y1
Simokawa, T1
Nisikawa, K1
Matusita, T1
Osima, K2
Yokota, S1
Eguchi, H1
Urasiński, I1
Wichert, K1
Zuk, E1
Gómez, H1
Colomer, R1
Hirokawa, N1
Hareyama, M1
Akiba, H1
Satoh, M1
Oouchi, A1
Tamakawa, M1
Sakata, K1
Nagakura, H1
Koito, K1
Harabuchi, Y1
Kataura, A1
Hinoda, Y1
Bailey, NP1
Stuart, NS1
Norfolk, D1
Grieve, RJ1
Simmons, AV1
Barnard, DL1
Farish, J1
Dunn, J1
Woodroffe, CM1
Stack, C1
Bloor, AJ1
Seale, JR1
Marcus, RE1
Atlan-Gepner, C1
Bouabdallah, R1
Valero, R1
Coso, D1
Vialettes, B1
Rafel, M1
Esteve, J1
Cervantes, F1
Velasco, M1
Serra, A1
Campo, E1
Montserrat, E1
Nishida, S1
Kuroko, K1
Hoshino, T1
Iwamoto, T2
Shirai, C1
Yalçin, S1
Kars, A1
Ozişik, Y1
Tekuzman, G1
Ozyilkan, O1
Celik, I1
Barişta, I1
Güllü, I1
Güler, N1
Baltali, E1
Firat, D1
Kersten, MJ1
Verduyn, TJ1
Reiss, P1
Evers, LM1
de Wolf, F1
van Oers, MH1
Ito, M1
Nishikawa, K1
Horikoshi, Y2
Anami, K2
Kaneko, Y1
Kataoka, S1
Chin, M1
Watanabe, A2
Van Leeuwen-Stok, EA1
Jonkhoff, AR1
Visser-Platier, AW1
Dräger, LM1
Teule, GJ1
Schuurhuis, GJ1
Plantier-Colcher, I1
Simon, M1
Detourmignies, L1
Jouet, JP1
Fenaux, P1
Bauters, F1
Takimoto, Y1
Eguchi, M1
Eguchi-Ishimae, M1
Imanaka, F1
Kamada, N1
Bremnes, RM1
Bremnes, Y1
Dønnem, T1
Xiros, N1
Samantas, E2
Raptis, S1
Dranitsaris, G1
Altmayer, C1
Quirt, I1
Farrell, AM1
Henry, K1
Woodrow, D1
Francis, N1
Newlands, ES2
Mitchell, DN1
Cream, JJ1
Macpherson, N1
Lesack, D1
Klasa, R1
Horsman, D1
Connors, JM1
Barnett, M1
Gascoyne, RD1
Tondini, C1
Zanini, M1
Giardini, R1
Rampinelli, I1
Bufalino, R1
Tarumi, T1
Koizumi, K1
Takano, H1
Fukada, Y1
Nishio, M1
Fujie, T1
Ohnishi, K1
Kohno, M1
Sato, N1
Sekiguchi, S1
Koike, T1
Tomlinson, J1
Tighe, M1
Johnson, S1
Stone, R1
Nicholson, AG1
Rule, S1
Fitoussi, O1
Simon, D2
Makke, J1
Scrobohaci, ML1
Bibi Triki, T1
Hennequin, C1
Schrappe, M1
Tiemann, M1
Ludwig, WD1
Yakisan, E1
Zimmermann, M1
Mann, G1
Ebell, W1
Klingebiel, T1
Graf, N1
Kremens, B1
Müller-Weihrich, S1
Plüss, HJ1
Zintl, F1
Henze, G1
Riehm, H1
Jerkeman, M1
Anderson, H1
Dictor, M1
Hagberg, H1
Johnson, A1
Kaasa, S1
Kvaløy, S1
Sundström, C1
Akerman, M2
Harries, SR1
Fox, BM1
Williams, MP1
McBride, NC2
Ward, MC2
Mills, MJ2
Eden, AG1
Hughes, A2
Cavenagh, JD2
Lamont, A1
Kelsey, SM2
Vaughan, B1
Vaughan, G1
Yamazaki, T1
Kura, Y1
Sawada, U1
Takemoto, Y2
Wada, H1
Takatsuka, H2
Kakishita, E3
Re, D1
Schwenk, A1
Hegener, P1
Bamborschke, S1
Diehl, V1
Tesch, H1
Mir, N1
Edmonson, R1
Yeghen, T1
Rashid, H1
Koharasawa, H1
Miyashita, H1
Ogawa, K1
Várkonyi, J1
Zalatnai, A1
Timár, J1
Matolcsi, A1
Falus, A1
Bencsáth, M1
László, V1
Pócsik, E1
Kotlán, B1
Császár, A1
Suzuki, K1
Sai, S1
Kato, K1
Murase, T1
Geetha, N1
Jayasree, K1
Ittiyavirah, AK1
Lali, VS1
Nair, MK1
Raspagliesi, F1
Ditto, A1
Fontanelli, R1
Gallino, G1
Massone, PB1
De Palo, G1
Kuraishi, Y2
Miyake, M1
Kikuta, A1
Kawano, Y1
Mugishima, H1
Matsushita, T1
Cavalot, AL1
Preti, G1
Vione, N1
Nazionale, G1
Palonta, F1
Fadda, GL1
Peters, FP1
Lalisang, RI1
Fickers, MM1
Erdkamp, FL1
Wils, JA1
Houben, SG1
Wals, J1
Schouten, HC1
Mainwaring, PN1
Gregory, W1
Norton, AJ1
Hudson, GV1
Kitajima, H1
Tsudo, M1
Fujimoto, M1
Hayashi, K4
Ohno, H1
Konaka, Y1
Katsurada, T1
Arima, N1
Doi, S1
Moriguchi, T1
Brandt, L2
Nygren, P1
Glimelius, B1
Baba, K1
Yajima, M1
Minagawa, N1
Kazama, A1
Grant, I1
Schey, S1
Gray, A1
Cervi, P1
Picozzi, VJ1
Pohlman, BL1
Lawless, GD1
Lee, MW1
Kerr, RO1
Ford, JM1
Carter, WB1
Akutsu, M1
Kano, Y2
Ogawa, M3
Miura, A1
Tatsumi, N1
Lanza, F1
Campioni, D1
Moretti, S1
Dominici, M1
Punturieri, M1
Focarile, E1
Pauli, S1
Dabusti, M1
Tieghi, A1
Bacilieri, M1
Scapoli, C1
De Angeli, C1
Galluccio, L1
Castoldi, G1
Schley, G1
Kauffold, D1
Guse, E1
Slucka, S1
Jeschke, M1
Wessendorf, S1
Lichter, P1
Schwänen, C1
Fritz, B1
Walenta, K1
Döhner, H1
Nguyen, TP1
Pfreunschuh, M1
Nishiyama, Y1
Fukunaga, K1
Satoh, K1
Ohkawa, M1
Yong, W1
Zheng, W1
Zhang, Y1
Basaran, M1
Bavbek, ES1
Sakar, B1
Eralp, Y1
Alici, S1
Tas, F1
Yaman, F1
Dogan O, O1
Camlica, H1
Onat, H1
Siemens, HJ1
Gerke, P1
Steinhoff, J1
Roth-Isigkeit, A1
Wagner, K1
Brückner, S1
Malik, R1
Gabor, LJ1
Foster, SF1
McCorkell, BE1
Canfield, PJ1
Okada, M1
Wakae, T1
Zouhair, A1
Weber, D1
Belkacémi, Y1
Ketterer, N1
Villà, S1
Scandolaro, L1
Bieri, S1
Studer, G1
Delacretaz, F1
Girardet, C1
Mirimanoff, RO1
Ozsahin, M1
Wilder, DD1
Ogden, JL1
Jain, VK1
Ingram, RM1
Williams, ME1
Fintel, WA1
Ross, M2
Dimopoulos, MA1
Mellou, S1
Tsatalas, C1
Papadopoulos, A1
Papageogriou, E1
Papasavvas, P1
Morschauser, F1
Marit, G1
Casasnovas, O1
Reman, O1
Molina, T1
Baiocchi, OC1
Navajas, EV1
Duarte, LC1
Alves, AC1
Andrade, AL1
Kerbauy, J1
Oliveira, JS1
Klener, P1
Donner, L1
Bowles, CA1
Lucas, D1
Graw, RG1
Tigges, FJ1
Schmülling, RM1
Hiller, E1
Waller, HD1
Wilms, K1
Mattsson, W1
von Eyben, F1
Turesson, I1
Landberg, TG1
Håkansson, LG1
Möller, TR2
Mattsson, WK1
Johansson, BG1
Killander, DC1
Molin, BF1
Westling, PF1
Lenner, PH1
Dahl, OG1
Shramko, AF2
Poddubnaia, IV2
Farr, MJ1
Newling, DW1
Raper, C1
Turner, A1
Lenhart, JE1
Yoshikawa, S1
Persohn, LK1
Drewinko, B1
Loo, TL1
Schuler, D1
Koós, R1
Révész, T1
Virág, I1
Gálfi, I1
Clarke, PR1
Saunders, M1
Exss, R1
Weber, HP1
Aungst, CW1
Mittelman, A1
Murphy, GP1
Kónyves, I1
Lindberg, G1
Berg, M1
Wilander, E1
Eriksson, A1
Pichert, G1
Peters, J1
Stahel, RA1
Dommann, C1
Joss, R1
Gebbers, JO1
Kroner, T1
Sulser, H1
Honegger, HP1
Maurer, R1
Joensuu, H1
Turpeenniemi-Hujanen, T1
Kuzuyama, Y1
Sonoda, Y1
Okuda, T1
Takashima, T1
Misawa, S1
Kashima, K1
Nakagawa, H1
Fujii, H1
Moriwaki, Y1
Naka, M1
Takagi, S1
Hidaka, T1
Takahashi, S1
Hada, T1
Nishigami, T1
Higashino, K1
Korman, DB1
Snimshchikov, VA1
Kiselev, AV1
Gordina, GA1
Morozova, OV1
Gubin, AN1
Kosechkina, NA1
Maruyama, F2
Ezaki, K1
Shimizu, K3
Ino, T2
Matsui, T2
Sobue, R2
Shinkai, K2
Miyazaki, H1
Oksenjendler, E1
Gabarre, J1
Gastaldi, R1
Farcet, JP1
Thyss, A1
Raphael, M1
Damonte, JC1
Dufour, P2
Maloisel, F1
Liu, KL1
Ortiz, S1
Bergerat, JP2
Oberling, F2
Ishige, K1
Matsue, K1
Tsukuda, K1
Sakai, C3
Demina, EA1
Evtushenko, VV1
White, L1
Siegel, SE1
Quah, TC1
Wakayama, T1
Kunika, N1
Kubomatsu, Y1
Chisa, M1
Jakić-Razumović, J1
Uzarević, B1
Petrovecki, M1
Marusić, M1
Radman, I1
Labar, B1
Guerci, AP1
Burtin, P1
Mattei, S1
Matthews, JR1
Miyazaki, E1
Kanamaru, A1
Nagai, K3
Shibata, H1
Horiuti, A1
Tsubaki, K1
Yonezawa, T1
Chubachi, A2
Takatsu, H1
Yamaguchi, A2
Nishimura, S2
Nakayama, Y1
Akihama, T1
Miura, S1
Saitoh, M1
Watanuki, T1
Santarelli, MT1
Erazo, A1
Diaz Maqueo, JC1
Lluesma Goñalons, M1
Cervantes, G1
Garcia Vela, EL1
Corrado, C1
Magnasco, H1
Oguro, M2
Hiruma, K1
Asai, T1
Aotsuka, N1
Hirasawa, A1
Wakita, H1
Endoh, N1
Yoshida, S1
Kosaka, M1
Mizuguchi, T1
Miyamoto, Y1
Fuller, L1
Redman, J1
Durr, E1
Allen, P1
Holmes, L1
Santini, G1
Capnist, G1
Coser, P1
Contu, A1
Porcellini, A1
Rizzoli, V1
Sertoli, M1
Rancan, L1
Salvagno, L1
Mazza, P1
Gherlinzoni, F1
Bocchia, M1
Fiacchini, M1
Martelli, M1
Moretti, G1
Pitini, V1
Abbadessa, V1
Nakayama, S1
Yabe, H1
Loos, U1
Musch, E1
Malek, M1
Riedel, E1
Nielsen, SH1
Hasselbalch, HC1
Birgens, HS1
Thomas, DW1
Gray, W1
Tate, RJ1
Hvizdala, EV2
Berard, C2
Callihan, T2
Falletta, J2
Sabio, H2
Shuster, JJ2
Sullivan, M2
Wharam, MD2
Ba-Thike, K1
Oo, N1
Bruntsch, U1
Lötzke, E1
Oyama, A1
Suzuki, H1
Watkin, SW1
Murayama, K1
Katsumi, T1
Watanabe, K1
Konishi, K1
Lobo, AJ1
Foster, PN1
Burke, DA1
Johnston, D1
Axon, AT1
Wheeler, K1
Chessells, JM1
Shima, N1
Takouda, K1
Tada, A3
Ohnoshi, T4
Ueoka, H3
Ueno, K4
Murashima, M3
Mizuta, J1
Kimura, I5
Hepplestone, A1
Gilchrist, NL1
Dagg, JH1
Evans, IL1
Soukop, M1
Garcia, JJ1
Duclos, B1
Ieki, R1
Goto, H1
Kouzai, Y1
Morisaki, T1
Asano, S1
Shimada, K1
Sotnikov, VM1
Polianskaia, AM2
Pan'shin, GA1
Ingberman, IaKh1
Kaplanskaia, IB1
Ohtake, S4
Kanno, M4
Kondo, K1
Okafuji, K1
Kanai, M1
Butterworth, SJ1
Sakamoto, S1
Lennert, K1
Wellens, W1
Schmidt, M1
Gassel, WD1
Kolb, T1
Hässler, R1
Hara, K1
Kunii, A1
Smith, DB1
Ledermann, JA1
Boesen, E1
Begent, RH1
Rustin, GJ1
Glaser, MG1
Bagshawe, KD1
Domingo Albós, A1
Callís, M1
Juliá, A1
Vilá, J1
Zuazu, J1
Puig, J1
Petit, J1
Fernández-Sevilla, A1
Errington, RD1
Coe, MA1
Warenius, HM1
Yamazaki, H2
Nagamine, D1
Aoyama, T1
Funakoshi, S1
Isogai, Y1
Kanehira, C1
Glynne-Jones, R1
Vernon, CC1
Bell, G1
Ota, K1
Yunoki, K1
Konda, S1
Takatsuki, K1
Ichimaru, M1
Tominaga, S1
Chuang, MW1
Tzeng, CH1
Chiou, TJ1
Chiu, CF1
Liu, JH1
Chen, PM1
Brown, T1
Bennett, B1
Moore, NR1
Imura, H1
Ito, N1
Tsukasaki, K1
Momita, S1
Murata, K1
Tokunaga, S1
Kohno, T1
Itoyama, T1
Toriya, K1
Kuriyama, K1
Hirai, J3
Naito, K1
Nakamura, E1
Shinohara, M1
Kashimura, M1
Sasayama, T1
Kusano, S1
Kashimura, Y1
Wagstaff, J1
Todd, I1
Deakin, D1
Wilkinson, P1
Jones, M1
Al-Ismail, SA1
Whittaker, JA1
Gough, J1
Bird, MC1
Bosanquet, AG1
Forskitt, S1
Gilby, ED1
Tachimori, K2
Saito, Y2
Kakinoki, Y1
Maekawa, I1
Kawamura, T1
Miyake, T1
Kurosawa, M1
Okabe, M1
Kamiya, K1
Sasaki, O1
Nemoto, K1
Honma, K1
Ohnishi, Y1
Abe, A1
Camitta, BM1
Casper, JT1
Kun, LE1
Lauer, SJ1
Starshak, RJ1
Oechler, HW1
Randall, J1
Obeid, ML1
Blackledge, GR1
Namba, K1
Imashuku, S1
Arakawa, S1
Todo, S1
Esumi, N1
Shimizu, Y1
Fujiwara, F1
Tsunamoto, K1
Morioka, Y1
Fushiki, S1
Duker, JS1
Shields, JA1
Khrennikova, GIu1
Sevast'ianova, MG1
Naumova, GA1
Tachimori, Y1
Kato, H1
Watanabe, H1
Iizuka, T1
Minato, K1
Yamaguchi, H1
Mukai, K1
Kliuchanskaia, NV2
Iliukhin, AV2
Setdikov, RA1
Mustiatsé, LZ1
Korchmaru, IF1
Takeyama, H1
Yano, K1
Fukutani, H1
Watanabe, E1
Horikoshi, N1
Inagaki, J1
Inoue, K1
Imajo, K1
Mukaiyama, T1
Garg, A1
Kochupillai, V1
Ponomar'kov, VI1
Stenzel, L1
Krug, K1
Schingnitz, G1
Keidan, SE1
Maas, B1
Ruhrmann, G1
Wilmanns, W1
Gregory, MC1
Hughes, JT1
Keipert, JA1
Wishart, JM1
Cho, ES1
Connolly, E1
Porro, RS1
Garwicz, S1
Landberg, T1
Barnett, LB1
Schwartz, E1
Mansurov, AN1
Stojcevski, T1
Fröscher, W1
Vliegen, J1
Abelson, HT1
Rabstein, LS1
Obara, Y1
Sasaki, M1
Makino, S1
Garrett, MJ1
Glazebrook, GA1
el-Akkad, SM1
Shakir, MA1
Mashburn, LT2
Stevens, J1
Stevens, YW1
Hollander, VP2
Tiwari, RM1
Hill, JM1
Roberts, J1
Loeb, E1
Khan, A1
MacLellan, A1
Hill, RW1
Streliukhina, NV1
Hall, TC1
Choi, OS1
Abadi, A1
Krant, MJ1
Rossolimo, OK1
Erokhina, NM1
Marsden, JA1
Burton, AF1
Leckie, WJ1
Tothill, P1
Ambellan, E1

Clinical Trials (16)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Trial of Rituximab and Short Duration Chemotherapy Followed by Zevalin as First-Line Treatment for Patients With Low Grade Follicular Non-Hodgkin's Lymphoma[NCT00193440]Phase 240 participants Interventional2002-04-30Completed
Phase 3 Study of Dose-Dense Therapy Versus CHOP in Aggressive Non-Hodgkin's Lymphoma[NCT00517894]0 participants Expanded AccessNo longer available
The Value of Dexamethasone Versus Prednisolone During Induction and Maintenance Therapy of Prolonged Versus Conventional Duration of L-Asparaginase Therapy During Consolidation and Late Intensification, and of Corticosteroid + VCR Pulses During Maintenanc[NCT00003728]Phase 31,500 participants (Anticipated)Interventional1998-12-31Active, not recruiting
Gem-CHOP: A Randomized Phase II Study of Gemcitabine Combined With CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma[NCT00079261]Phase 225 participants (Actual)Interventional2004-01-31Completed
A Retrospective and Prospective Observational Study Reviewing Supportive Care Management of NHL Patients Treated With CHOP-14 or 21 Chemotherapy(With or Without Rituximab) (CHOP = Cyclophosphamide, Hydroxyrubicin (Adriamycin), Oncovin (Vincristine), Predn[NCT00903812]1,837 participants (Actual)Observational2007-02-28Completed
Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell[NCT02916316]127 participants (Actual)Observational2014-02-12Active, not recruiting
Candidate Gene Polymorphisms and Response to Rituximab-CHOP in Patients With Diffuse Large Cell Lymphoma[NCT00590941]52 participants (Actual)Interventional2005-02-28Completed
Phase II Trial Investigating Tailoring First-Line Therapy For Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Based on Mid-Treatment Positron Emission Tomography (PET) Scan Results[NCT00324467]Phase 2150 participants (Actual)Interventional2006-08-31Active, not recruiting
A Pilot Study of 18F Fluorothymidine (FLT) PET/CT in Lymphoma[NCT00775268]Phase 1/Phase 231 participants (Actual)Interventional2008-09-29Terminated
Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Pr[NCT00053768]Phase 3392 participants (Actual)Interventional2002-04-30Completed
LINFOTARGAM: First-line Treatment With Dose-dense Chemotherapy Plus Rituximab (R-CHOP/14) and Highly Active Antiretroviral Therapy (HAART) in Patients With Diffuse Large B Cell Lymphoma (DLBCL) and Infection With the Human Immunodeficiency Virus (HIV)[NCT00466258]Phase 450 participants (Anticipated)Interventional2006-10-31Completed
Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)[NCT00388193]Phase 220 participants (Anticipated)Interventional2006-08-31Completed
Treatment Regimen or Children or Adolescent With Mature B-cell NHL or B-AL in China[NCT02405676]Phase 2/Phase 3200 participants (Anticipated)Interventional2015-01-31Active, not recruiting
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.[NCT05049473]Phase 2100 participants (Anticipated)Interventional2014-01-31Recruiting
A Prospective, Open, Randomized Controlled, Multi-center Phase III Clinical Trial Comparing High-dose Epirubicin and Standard-dose Epirubicin in R±CEOP in Newly Diagnosed Young Patients With Medium/High-risk Diffuse Large B-cell Lymphoma[NCT03151044]Phase 3408 participants (Anticipated)Interventional2016-07-31Recruiting
Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients Aged From 18 to 59 Years With Diffuse Large B-cell Lymphoma and a Age-adjusted IPI of 1.[NCT00140595]Phase 3380 participants (Anticipated)Interventional2003-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With Non-serious Adverse Events Assessed by the Common Terminology Criteria for Adverse Events (CTCAE v4.0)

Here is the number of participants with non-serious adverse events assessed by the Common Terminology Criteria for Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life-threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT00775268)
Timeframe: Date treatment consent signed to date off study, approximately 4 years, 7 months and 9 days.

InterventionParticipants (Count of Participants)
Participants Scanned at Baseline & After Chemotherapy7
Participants Scanned in the Evaluation of Residual Masses After Therapy20

Time to Progression

The time to progression (defined as time in months from 3'-deoxy-3'-[18F] fluorothymidine (FLT)-scan until patient progressed) was compared between the two groups (patients with higher Maximum Standard Uptake Value (SUVmax) vs lower SUVmax, using the median SUV value). (NCT00775268)
Timeframe: up to 4.5 years

InterventionMonths (Mean)
Participants Scanned After Chemotherapy18.29

18F- Fluorothymidine (FLT) Uptake Within the Tumor(s) Between Baseline vs Completion of Therapy Scans

FLT uptake within the tumor(s) using standard uptake value (SUVmax) was compared between baseline and completion of therapy scans. (NCT00775268)
Timeframe: up to 4.5 years

InterventionSUVmax (Mean)
BaselineCompletion of therapy scans
Participants Scanned at Baseline & After Chemotherapy9.150.9

18F- Fluorothymidine (FLT) Uptake, Positron-emission Tomography (PET) Standard Uptake Value (SUV)Max in Malignant Residual Tumors Versus Benign Lesions After Therapy

FLT uptake was calculated within malignant residual tumors versus benign lesions using maximum standard uptake value (SUVmax). (NCT00775268)
Timeframe: up to 4.5 years

InterventionSUVmax (Mean)
Malignant LesionsBenign Lesions
Participants Scanned in the Evaluation of Residual Masses After Therapy5.51.7

18F-fluorodeoxyglucose (18FDG) Standardized Uptake Values (SUV) Estimated Maximum and Tumor: Blood Pool Ratio at 1-hour Post-injection

After 1 hour post-injection of fluorodeoxyglucose (FDG), the maximum uptake value (SUVmax) (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was calculated was calculated within the residual mass. The ratio between SUVmax within the residual mass and SUVmean in the pool blood was measured. (NCT00775268)
Timeframe: up to 3.5 years

InterventionSUVmax/Tumor blood ratio (Number)
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10Patient 11Patient 12Patient 13Patient 14Patient 15Patient 16Patient 17Patient 18Patient 19Patient 20Patient 21
Participants Scanned in the Evaluation of Residual Masses After Therapy4.68.410.13.86.96.75.44.74.610.34.83.84.06.96.415.811.22.13.83.59.1

3'-Deoxy-3'-[18F]-Fluorothymidine (FLT) Dynamic Influx Parameter (Ki) Standardized Uptake Values (SUV) Estimated Maximum at 1- and 2-hours Post-injection

The maximum uptake value (SUVmax) (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was calculated within the residual mass at 1 h and at 2 hours post-injection of FLT. (NCT00775268)
Timeframe: up to 3.5 years

,
InterventionSUV (Mean)
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10Patient 11Patient 12Patient 13Patient 14Patient 15Patient 16Patient 17Patient 18Patient 19Patient 20Patient 21Overall participants
Participants Scanned in the Evaluation of Residual Masses After Therapy at 1 Hour Post Injection0.72.08.91.61.37.53.41.66.52.32.52.27.64.51.93.94.77.91.11.56.43.6
Participants Scanned in the Evaluation of Residual Masses After Therapy at 2 Hours Post InjectionNA1.8NA0.87.94.63.21.26.02.02.41.57.44.21.63.64.57.91.1NA5.42.9

Number of Participants With the Presence/Absence of Abnormal 18F- Fluorothymidine (FLT) Uptake, and Positive/Negative Biopsy

A positive malignant residual mass was defined as focal 18F- Fluorothymidine (FLT) uptake within the residual mass greater than the normal mediastinal background uptake. FLT uptake within the mass lower than the mediastinal was considered non-malignant. The positive/negative FLT uptake was correlated with biopsy results within the residual mass (presence or absence of malignant tumor cells). (NCT00775268)
Timeframe: Up to 3.5 years

InterventionParticipants (Count of Participants)
Presence of FLT uptakeAbsence of FLT uptake and FLT uptake lower than normal mediastinumPositive BiopsyNegative BiopsyBiopsy not performed
Participants Scanned in the Evaluation of Residual Masses After Therapy9127410

Tumor Uptake With Fluorothymidine (FLT) - Maximum Standard Uptake Value (SUVmax)

The maximum standard uptake value (SUVmax) (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was measured within the tumor(s). The SUVmax was defined as the uptake value of the hottest pixels, within a volume of interest containing the entire tumor(s). (NCT00775268)
Timeframe: Up to 4.5 years

,
InterventionSUV (Mean)
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Group-level (at baseline and after completion of therapy)
Participants Scanned After Completion of Therapy0.91.01.30.90.60.90.9
Participants Scanned at Baseline10.94.810.39.19.39.29.2

Tumor(s) Maximum Standard Uptake Value (SUVmax) at Baseline and at Mid-treatment (Post-2 Cycles) Scan

The SUVmax (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was measured within the tumor(s). The SUVmax was defined as the uptake value of the hottest pixels, within a volume of interest containing the entire tumor(s). SUVmax was calculated at baseline and after 2-cycles of therapy. (NCT00775268)
Timeframe: Up to 4.5 years

InterventionSUVmax (Mean)
Baseline2-cycles post treatment
Participants Scanned at Baseline, at 2 Cycles & After ChemotherapyChemotherapy9.151.5

Tumor(s) Maximum Standard Uptake Value (SUVmax) at Baseline Scan and SUVmax After Completion Scan in Responders and Non-responders' Patients

The SUVmax (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was measured within the tumor(s). The SUVmax was defined as the uptake value of the hottest pixels, within a volume of interest containing the entire tumor(s). SUVmax was calculated at baseline and after completion of therapy. (NCT00775268)
Timeframe: up to 4.5 years

InterventionStandard Uptake Value (SUV) - units (Median)
BaselineAfter completion of scan
Participants Scanned at Baseline & After Chemotherapy9.11.5

Reviews

36 reviews available for prednisolone and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Lipomatosis: an unusual side-effect of cytotoxic chemotherapy?
    Acta dermato-venereologica, 2010, Volume: 90, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lipomatosis; Lymphoma, Non-Hodgkin; Male; Me

2010
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
    Seminars in oncology, 2002, Volume: 29, Issue:4 Suppl 13

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti

2002
[Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2002, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Aged; Comorbidity; Cytomegalovirus Infections; Epstein-Barr Virus Infections; Fem

2002
Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas.
    Clinical lymphoma, 2002, Volume: 3 Suppl 1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2002
Treatment paradigms in aggressive non-Hodgkin's lymphoma in elderly patients.
    Clinical lymphoma, 2002, Volume: 3 Suppl 1

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-

2002
[Erythema nodosum association with malignant lymphoma].
    Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Dif

2003
Non-hodgkins lymphoma.
    Clinical evidence, 2003, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Mo

2003
Primary adrenal lymphoma presenting as Addison's disease: case report and review of the literature.
    Annals of hematology, 2004, Volume: 83, Issue:7

    Topics: Addison Disease; Adrenal Cortex Neoplasms; Aged; Aged, 80 and over; Antineoplastic Combined Chemothe

2004
Primary central nervous system lymphoma (PCNSL) in immunocompetent adults: analysis of a retrospective series of patients treated using idarubicin-containing regimen and radiotherapy.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Ther

2004
The impact of conventional and high-dose therapy for lymphoma on fertility.
    Clinical lymphoma, 2004, Volume: 5, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide;

2004
Testicular granulocytic sarcoma, a source of diagnostic confusion.
    Urology, 2004, Volume: 64, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nucleus; Cyclophospha

2004
[Case of non-Hodgkin lymphoma with acute renal failure successfully treated with chemotherapy].
    Nihon Jinzo Gakkai shi, 2004, Volume: 46, Issue:8

    Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone

2004
New treatment strategies for aggressive lymphoma.
    Seminars in oncology, 2004, Volume: 31, Issue:6 Suppl 15

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi

2004
Blistering mucocutaneous diseases of the oral mucosa--a review: part 2. Pemphigus vulgaris.
    Journal (Canadian Dental Association), 2006, Volume: 72, Issue:1

    Topics: Anti-Inflammatory Agents; Autoantibodies; Desmoglein 3; Desmosomes; Gingivitis; Humans; Lymphoma, No

2006
Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.
    Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:10

    Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic

2007
[Malignant lymphoma of the thyroid].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Volume: 65, Issue:11

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2007
CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).
    European journal of haematology, 2008, Volume: 80, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non

2008
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.
    Cancer, 1994, Nov-01, Volume: 74, Issue:9 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethaso

1994
Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
    Bailliere's clinical haematology, 1994, Volume: 7, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo

1994
The treatment of non-Hodgkin's lymphoma with mitoxantrone-containing regimens.
    Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom

1995
Primary lymphoma of the esophagus.
    Journal of clinical gastroenterology, 1996, Volume: 23, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Ad

1996
Malignant tumours after renal transplantation.
    Scandinavian journal of urology and nephrology, 1996, Volume: 30, Issue:5

    Topics: Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Tran

1996
[Value of radiotherapy in disseminated high-grade non-Hodgkin's lymphoma].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1997, Volume: 173, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials,

1997
Chemotherapy in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphoma.
    Wiener klinische Wochenschrift, 1998, Jan-16, Volume: 110, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos

1998
[Treatment of lymphoma in the aged].
    Medicina clinica, 1998, May-02, Volume: 110, Issue:15

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubi

1998
[Primary MALT-type lymphoma of the breast].
    Sangre, 1998, Volume: 43, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph

1998
Treatment of aggressive non-Hodgkin's lymphoma.
    Seminars in oncology, 1999, Volume: 26, Issue:5 Suppl 14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immunophenoty

1999
[Treatment of intermediate and high grade non-Hodgkin's lymphoma].
    Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub

2000
[A case of malignant lymphoma of the epididymis].
    Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality

2000
Isolated primary non-Hodgkin's malignant lymphoma of the larynx.
    The Journal of laryngology and otology, 2001, Volume: 115, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Larynge

2001
A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma.
    Acta oncologica (Stockholm, Sweden), 2001, Volume: 40, Issue:2-3

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

2001
Combination chemotherapy and rituximab.
    Anti-cancer drugs, 2001, Volume: 12 Suppl 2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti

2001
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclopho

2001
Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrence.
    Clinical lymphoma, 2002, Volume: 2, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Cyclophos

2002
Non-Hodgkin's lymphomas in children. II. Treatment.
    Critical reviews in oncology/hematology, 1992, Volume: 13, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protoco

1992
[Problems of cancer treatment in the elderly from the viewpoint of the chemotherapist--focusing on malignant lymphomas as a model of chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom

1990

Trials

134 trials available for prednisolone and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressi
    British journal of haematology, 2013, Volume: 162, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem

2013
Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.
    Veterinary and comparative oncology, 2016, Volume: 14 Suppl 1

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti

2016
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    American journal of hematology, 2014, Volume: 89, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradioth

2014
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
    BMC cancer, 2009, May-18, Volume: 9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; D

2009
Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
    Clinical lymphoma & myeloma, 2009, Volume: 9, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti

2009
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
    Annals of hematology, 2010, Volume: 89, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexametha

2010
Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha

2010
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas

2010
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.
    Blood, 2010, Jul-08, Volume: 116, Issue:1

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced L

2010
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54).
    European journal of haematology, 2011, Volume: 86, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxoru

2011
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
    Bone marrow transplantation, 2012, Volume: 47, Issue:12

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols;

2012
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclophosphamide;

2002
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Nov-15, Volume: 20, Issue:22

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide

2002
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:2

    Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro

2003
Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.
    Annals of hematology, 2003, Volume: 82, Issue:2

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas

2003
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.
    The hematology journal : the official journal of the European Haematology Association, 2003, Volume: 4, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined

2003
A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:4

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disea

2003
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha

2003
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jul-15, Volume: 21, Issue:14

    Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Co

2003
Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
    Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administra

2004
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Aug-01, Volume: 22, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th

2004
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.
    Acta oncologica (Stockholm, Sweden), 2004, Volume: 43, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans;

2004
Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing lymphomas: results of a phase I trial.
    Acta haematologica, 2004, Volume: 112, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth

2004
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Dec-01, Volume: 22, Issue:23

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot

2004
A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002.
    International journal of hematology, 2004, Volume: 80, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

2004
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
    International journal of hematology, 2005, Volume: 81, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F

2005
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Haematologica, 2005, Volume: 90, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop

2005
Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma.
    British journal of haematology, 2005, Volume: 130, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cyclophosphami

2005
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
    International journal of hematology, 2006, Volume: 83, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disea

2006
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop

2005
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
    British journal of cancer, 2006, Mar-27, Volume: 94, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyc

2006
Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness.
    International journal of hematology, 2005, Volume: 82, Issue:5

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemothe

2005
Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma.
    Cancer science, 2006, Volume: 97, Issue:4

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined

2006
A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.
    International journal of radiation oncology, biology, physics, 2006, Sep-01, Volume: 66, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

2006
Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma.
    Hematological oncology, 2006, Volume: 24, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Surv

2006
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide

2007
Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.
    Acta haematologica, 2006, Volume: 116, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans;

2006
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette

2007
Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:5

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological A

2008
A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:9

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

2007
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxo

2008
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr

2008
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
    British journal of haematology, 2008, Volume: 141, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromoso

2008
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi

2008
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
    European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:11

    Topics: Adult; Aged; Chlorambucil; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination;

1982
[Results of a cooperative clinical study of leumase].
    Problemy gematologii i perelivaniia krovi, 1980, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Aged; Asparaginase; Child; Child, Preschool; Clinical Trials as Topic; Drug Thera

1980
[Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
    Problemy gematologii i perelivaniia krovi, 1981, Volume: 26, Issue:4

    Topics: Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Lymph

1981
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1994
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
    British journal of cancer, 1994, Volume: 70, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Ch

1994
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
    British journal of cancer, 1994, Volume: 70, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone

1994
Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma.
    Cancer, 1994, Oct-01, Volume: 74, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm

1994
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1994
Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
    International journal of radiation oncology, biology, physics, 1995, Oct-15, Volume: 33, Issue:3

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of

1995
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined

1995
Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di

1995
MACOP-B in advanced non-Hodgkin's lymphoma.
    American journal of clinical oncology, 1993, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamid

1993
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:14

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto

1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:8

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone

1993
[MMIP chemotherapy for the treatment of the relapsed and refractory non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifos

1995
Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
    International journal of hematology, 1995, Volume: 61, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1995
Mitoxantrone, chlorambucil and prednisolone in the treatment of non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:5-6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Lymphoma,

1994
A six-drug regimen (MAPECO) for intermediate or high-grade non-Hodgkin's lymphoma.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1994
Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:9

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1994
Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
    Seminars in hematology, 1994, Volume: 31, Issue:2 Suppl 3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1994
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1994
NOPE for relapsed aggressive diffuse non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:4-5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Heart Failure; Humans; Lymphoma,

1993
[A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols

1994
EPIC: an effective low toxicity regimen for relapsing lymphoma.
    British journal of cancer, 1993, Volume: 68, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Drug A

1993
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:2

    Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burki

1993
The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide;

1993
Anthracycline containing regimens in intermediate grade lymphoma. Italian Cooperative Study Group on Intermediate Grade Malignant Lymphoma.
    Leukemia & lymphoma, 1993, Volume: 10 Suppl

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Idarub

1993
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexametha

1996
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
    Leukemia & lymphoma, 1995, Volume: 17, Issue:3-4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophos

1995
P-COMM-B induction chemotherapy in intermediate and high grade non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1995, Volume: 18, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1995
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Combined Mod

1996
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
    British journal of cancer, 1996, Volume: 74, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etop

1996
[Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclopho

1997
Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:10

    Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose

1996
The in vivo effects of interleukin-3 on histamine levels in non-Hodgkin's lymphoma patients.
    Pharmacology & toxicology, 1997, Volume: 80, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Basophils; Cyclophosphamide; Doxorubici

1997
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Cyclophosphami

1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphami

1997
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
    British journal of cancer, 1997, Volume: 76, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Che

1997
Weekly chemotherapy using PMitCEBO in the palliation of recurrent non-Hodgkin's lymphoma.
    Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1997
For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marro

1998
[Treatment of children with non-Hodgkin's lymphoma with CCLSG NHL 855/890 protocols long-term outcome and incidence of secondary malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C

1998
[Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1998, Volume: 4, Issue:21

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Fr

1998
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Resp

1998
VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.
    European journal of haematology, 1998, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1998
Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Granulocyte Colony-

1998
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:11

    Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkyla

1998
The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases.
    Leukemia, 1999, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytara

1999
A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma.
    Haematologica, 1999, Volume: 84, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Idarubicin;

1999
Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma.
    PharmacoEconomics, 1997, Volume: 11, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin

1997
A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1999, Volume: 34, Issue:3-4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi

1999
CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.
    Seminars in oncology, 1999, Volume: 26, Issue:5 Suppl 14

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineo

1999
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1999
Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:3-4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy;

1999
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11 Suppl 1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distr

2000
Mobilization of peripheral blood stem cells by granulocyte-colony stimulating factors: comparison of a standard dose of glycosylated and mutated granulocyte-colony stimulating factor in non-Hodgkin's lymphoma patients following CHOP therapy.
    Drugs under experimental and clinical research, 2000, Volume: 26, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cyclophosphamide; D

2000
CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study. The Adult Lymphoma Treatment Study Gr
    European journal of haematology, 2000, Volume: 65, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo

2000
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
    Blood, 2001, May-15, Volume: 97, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

2001
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.
    Leukemia & lymphoma, 2001, Volume: 42, Issue:1-2

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide;

2001
[Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:12

    Topics: Aged; Alopecia; Anorexia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemo

2001
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclopho

2001
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease

2001
Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.
    American journal of clinical oncology, 2001, Volume: 24, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Admi

2001
Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
    Clinical lymphoma, 2002, Volume: 2, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; De

2002
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
    European journal of haematology, 2002, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols

2002
Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA study.
    British journal of haematology, 2002, Volume: 118, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cy

2002
A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
    Biomedicine / [publiee pour l'A.A.I.C.I.G.], 1977, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Aged; Chlorambucil; Clinical Trials as Topic; Female; Humans; Leukemia, Lymphoid;

1977
CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas: preliminary results of a randomized study.
    Cancer, 1979, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fema

1979
Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).
    Journal of surgical oncology, 1975, Volume: 7, Issue:6

    Topics: Chlorambucil; Clinical Trials as Topic; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; P

1975
MACOP-B regimen in non-Hodgkin's lymphoma.
    Acta oncologica (Stockholm, Sweden), 1992, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1992
Non-Hodgkin's lymphomas in children. II. Treatment.
    Critical reviews in oncology/hematology, 1992, Volume: 13, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protoco

1992
Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    Australian and New Zealand journal of medicine, 1992, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1992
[Co-operative on salvage chemotherapy with VP-16 for malignant lymphoma. Hanshin Study Group on Treatment for Hematological Disorders].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:4

    Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Et

1992
Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do

1992
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; C

1991
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto

1991
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Cyt

1991
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1991
Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
    Oncology, 1991, Volume: 48, Issue:4

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlora

1991
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
    Onkologie, 1990, Volume: 13, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Re

1990
Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly.
    American journal of clinical oncology, 1990, Volume: 13 Suppl 1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1990
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:1

    Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resi

1989
CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study.
    British journal of cancer, 1989, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1989
Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Deltaret

1988
[A comparative study of ABEP and ACOPE in the treatment of non-Hodgkin's lymphoma CS IV].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:9

    Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubi

1988
Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine

1988
A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma.
    Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C

1987
Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical

1987
[Mitoxantrone-containing combination chemotherapy in patients with non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophospham

1986
[Clinical study of non-Hodgkin's lymphoma--results of the Kanazawa University-Kurume University Cooperative Study on Malignant Lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubic

1986

Other Studies

310 other studies available for prednisolone and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study.
    International journal of hematology, 2020, Volume: 112, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Cyclophosphamide; Di

2020
Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy.
    British journal of haematology, 2021, Volume: 193, Issue:1

    Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Ant

2021
[Pyoderma gangraenosum after implantation of a shoulder endoprothesis].
    Der Orthopade, 2017, Volume: 46, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Arthroplasty, Replacemen

2017
Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo

2018
[Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protoc

2018
Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Veterinary and comparative oncology, 2018, Volume: 16, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lomustine; Lymp

2018
Orbital richter syndrome.
    Orbit (Amsterdam, Netherlands), 2013, Volume: 32, Issue:6

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers,

2013
Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:1

    Topics: Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols;

2014
Two tracheal BALT lymphoma patients successfully treated with chemotherapy including rituximab.
    Respiratory investigation, 2014, Volume: 52, Issue:2

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot

2014
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide;

2014
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined

2014
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biphenyl

2014
Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
    International journal of radiation oncology, biology, physics, 2015, Jan-01, Volume: 91, Issue:1

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha

2015
Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
    Veterinary and comparative oncology, 2016, Volume: 14 Suppl 1

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti

2016
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
    Chinese journal of cancer, 2015, Sep-14, Volume: 34, Issue:11

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha

2015
Granulocyte growth factor use in elderly patients with non-Hodgkin's lymphoma in the United States: adherence to guidelines and comparative effectiveness.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Febrile Neutrop

2016
Successful conservative management of campylobacter cholecystitis occurring post chemotherapy and rituximab: a rare disease entity.
    The New Zealand medical journal, 2015, Dec-04, Volume: 128, Issue:1426

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Campylobacter Infection

2015
Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
    Neoplasma, 2008, Volume: 55, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera

2008
Clinical investigations in aggressive non-Hodgkin lymphoma.
    Clinical advances in hematology & oncology : H&O, 2008, Volume: 6, Issue:9

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti

2008
Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphoma.
    PharmacoEconomics, 2009, Volume: 27, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cost-Benefit Analy

2009
Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, May-20, Volume: 27, Issue:15

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2009
[Primary non-Hodgkin lymphoma of the sternum].
    Archivos de bronconeumologia, 2009, Volume: 45, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Human

2009
Vesiculo-bullous dermatomyositis: report of three cases.
    Dermatology online journal, 2009, Apr-15, Volume: 15, Issue:4

    Topics: Anti-Inflammatory Agents; Breast Neoplasms; Dermatomyositis; Fatigue; Female; Follow-Up Studies; Hum

2009
Bilateral low-grade B-cell lymphoma of the breast: a case report with cytological, histological and immunohistochemical studies.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2009, Volume: 92, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Biopsy, Fine-Needle; Breast; C

2009
[A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:7

    Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineo

2009
Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma.
    Acta haematologica, 2009, Volume: 122, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartate-Ammonia Ligase; Fatal

2009
Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:11

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined

2009
CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Connective Tissue Diseases; Cyclophosp

2009
Generalized eruptive lentiginosis induced by chemotherapy.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Eruptions

2010
A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma.
    Cancer research, 2010, Mar-15, Volume: 70, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Et

2010
The 51st annual meeting of the American Society of Hematology.
    Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2010
[Tunisian experience in the treatment of aggressive non Hodgkin's lymphoma in adults: about 337 patients].
    Bulletin du cancer, 2010, Volume: 97, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti

2010
Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
    Annals of hematology, 2011, Volume: 90, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxo

2011
Lymphoma of the cavernous sinus mimicking Tolosa-Hunt syndrome in a child.
    Pediatric neurology, 2010, Volume: 42, Issue:5

    Topics: Brain Neoplasms; Cavernous Sinus; Child, Preschool; Diagnosis, Differential; Humans; Lymphoma, Non-H

2010
Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Cytarabi

2010
Continual reassessment method with multiple toxicity constraints.
    Biostatistics (Oxford, England), 2011, Volume: 12, Issue:2

    Topics: Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bo

2011
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:5

    Topics: Aged; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols

2011
Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
    Mycopathologia, 2011, Volume: 172, Issue:3

    Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Comb

2011
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Che

2012
Mediastinal huge non-Hodgkin's lymphoma causing compression of the main pulmonary artery trunk.
    BMJ case reports, 2012, Aug-02, Volume: 2012

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Constriction, Pathologic; Coronary Stenosis;

2012
Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP.
    Hematology (Amsterdam, Netherlands), 2013, Volume: 18, Issue:1

    Topics: Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cycl

2013
[Lesions in the nervous system during chemotherapy of acute leukosis and non-Hodgkin lymphomas].
    Klinicheskaia meditsina, 2012, Volume: 90, Issue:6

    Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Therapy, Combination; Female; Hu

2012
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

2002
Dose density and dose intensity: where does CHOP go from here?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug;

2002
Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relatio

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy

2002
Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma.
    European journal of haematology, 2002, Volume: 69, Issue:4

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Costs

2002
Autologous stem-cell transplantation as a component of initial treatment for poor-risk patients with aggressive non-Hodgkin's lymphoma: resolved issues versus remaining opportunity.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Nov-15, Volume: 20, Issue:22

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase III a

2002
Coeliac disease following high-dose chemotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2002, Volume: 14, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Disease; Cisplatin; Cyclophosphami

2002
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Pediatric hematology and oncology, 2003, Volume: 20, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch

2003
Salvage surgery for primary non-Hodgkin's lymphoma of the thyroid gland with histopathological complete response to radio-chemotherapy: report of a case.
    Surgery today, 2003, Volume: 33, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosph

2003
Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy.
    Annals of hematology, 2003, Volume: 82, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Blotting, Southern; Case-C

2003
[Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2003, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomark

2003
Cerebral toxoplasmosis after autologous peripheral blood stem cell transplantation.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:9

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop

2003
[Successes and hazards of highdosage cortisone (prednisolone) therapy of blood diseases].
    Die Medizinische Welt, 1962, Jun-02, Volume: 22

    Topics: Cortisone; Hematologic Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgk

1962
Large doses of prednisone and prednisolone in the treatment of malignant lymphoproliferative disorders.
    Annals of internal medicine, 1962, Volume: 57

    Topics: Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders

1962
[On the combined therapeutic use of a corticoid and an anabolic steroid].
    Minerva medica, 1962, Dec-19, Volume: 53

    Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenalectomy; Anemia; beta-Thalasse

1962
STEROID THERAPY IN LYMPHOID TUMOURS.
    British journal of cancer, 1963, Volume: 17

    Topics: Betamethasone; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Large B-Cell, Diff

1963
A CASE OF LYMPHOSARCOMA ASSOCIATED WITH MYOPATHY.
    British medical journal, 1964, Jul-04, Volume: 2, Issue:5400

    Topics: Axilla; Biopsy; Lymphoma; Lymphoma, Non-Hodgkin; Muscular Diseases; Neoplasms; Pathology; Prednisolo

1964
ATRIOVENTRICULAR DISSOCIATION IN A CASE OF RETICULOSARCOMATOSIS AND THE EFFECTS OF STEROID AND CO60 IRRADIATION.
    Japanese heart journal, 1964, Volume: 5

    Topics: Cobalt Isotopes; Electrocardiography; Heart Block; Heart Neoplasms; Humans; Leukemia; Lymphoma, Larg

1964
THE MANAGEMENT OF MALIGNANT GRANULOMA.
    Proceedings of the Royal Society of Medicine, 1964, Volume: 57

    Topics: Diagnosis; Diagnosis, Differential; Granuloma; Granulomatosis with Polyangiitis; Hodgkin Disease; Hu

1964
[THE RETICULO-ENDOTHELIAL SYSTEM AND LYMPHOSARCOMAS].
    La Riforma medica, 1964, May-23, Volume: 78

    Topics: Adolescent; Adrenal Cortex Hormones; Geriatrics; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follic

1964
[LEUKEMIC RETICULO-SARCOMATOSIS FOLLOWING METHYLTESTOSTERONE AND PREDNISOLONE TREATED PANMYELOPATHY AND THROMBOCYTOPENIA].
    Annales paediatrici. International review of pediatrics, 1964, Volume: 203

    Topics: Bone Marrow Diseases; Child; Drug Therapy; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-

1964
PREDNISOLONE SENSITIVITY AND CYTOLOGY OF VIABLE LYMPHOCYTES AS TESTS FOR CHRONIC LYMPHOCYTIC LEUKEMIA.
    Journal of the National Cancer Institute, 1964, Volume: 33

    Topics: Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphocytes; Lymphocyt

1964
DISSEMINATED HISTOPLASMOSIS FOLLOWING LONG-TERM STEROID THERAPY FOR RETICULOSARCOMA.
    British medical journal, 1965, Sep-11, Volume: 2, Issue:5462

    Topics: Adrenocorticotropic Hormone; Amphotericin B; Blood Transfusion; Bone Marrow Examination; Drug Therap

1965
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Cancer, 2003, Dec-01, Volume: 98, Issue:11

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot

2003
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 32, Issue:12

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo

2003
Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:12

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Te

2003
Urinary immunocytology for primary bladder B cell lymphoma.
    Urology, 2004, Volume: 63, Issue:2

    Topics: Aged; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocy

2004
Remitting seronegative symmetrical synovitis with pitting edema syndrome associated with non-Hodgkin's lymphoma: a case report.
    Clinical rheumatology, 2004, Volume: 23, Issue:2

    Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Edema; F

2004
[Salvage combination chemotherapy with cytarabine, carboplatin and steroids for relapsed or refractory non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Administration

2004
Outcome analysis for stage IE and IIE thyroid lymphoma.
    American journal of clinical oncology, 2004, Volume: 27, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha

2004
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
    European journal of haematology, 2004, Volume: 72, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Posit

2004
Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma.
    Journal of Korean medical science, 2004, Volume: 19, Issue:2

    Topics: Adult; Anemia, Hemolytic; Antineoplastic Agents, Hormonal; Autoimmune Diseases; Combined Modality Th

2004
Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapy.
    Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Combined Modal

2004
The limits of limited stage lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Aug-01, Volume: 22, Issue:15

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non

2004
[Alveolar hypoxemic interstitial pneumonia related to rituximab therapy].
    Revue des maladies respiratoires, 2004, Volume: 21, Issue:2 Pt 1

    Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murin

2004
Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jul-15, Volume: 22, Issue:14

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide;

2004
Non-Hodgkin's lymphoma following treatment of atopic eczema with cyclosporin A.
    Acta dermato-venereologica, 2004, Volume: 84, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Cyclosporine; Der

2004
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Nov-01, Volume: 22, Issue:21

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot

2004
[Case of obstructive jaundice as initial manifestation of non Hodgkin lymphoma in patient followed as chronic hepatitis C].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:8

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic

2004
Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:11

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineo

2004
Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:11

    Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antig

2004
Non-Hodgkin's lymphomas at Kenyatta the National Hospital Nairobi in the 1990's.
    East African medical journal, 2004, Volume: 81, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fe

2004
Effective treatment of indolent non-hodgkin's lymphomas with mitoxantrone, chlorambucil and prednisone.
    Onkologie, 2005, Volume: 28, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Di

2005
[Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy].
    Voprosy onkologii, 2004, Volume: 50, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration S

2004
An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report.
    World journal of gastroenterology, 2005, May-28, Volume: 11, Issue:20

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic

2005
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamid

2005
Simultaneous occurrence of der(1;7)(q10;p10) and t(14;18)(q32;q21) in non-Hodgkin's lymphoma: der(1;7) will appear as a secondary change in lymphoid neoplasia.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair

2005
Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:10

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biopsy; Cryptogenic Organizing Pneum

2005
[Non-Hodgkin malignant lymphoma of rib origin: report of a case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2005, Volume: 58, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyc

2005
Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:4

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Chromosomes,

2007
Fatal interstitial pneumonitis related to rituximab-containing regimen.
    Clinical lymphoma & myeloma, 2006, Volume: 6, Issue:5

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas

2006
Chemotherapy in the management of advanced gastointestinal non-Hodgkin's lymphoma complicated with entero-cutaneous fistula: a case report.
    African journal of medicine and medical sciences, 2005, Volume: 34, Issue:2

    Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Gastrointestinal Neoplasms; Glucocortic

2005
High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL).
    Leukemia & lymphoma, 2006, Volume: 47, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2006
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Pediatric hematology and oncology, 2006, Volume: 23, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabi

2006
Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.
    International journal of hematology, 2006, Volume: 84, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cyclophosphamide; D

2006
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D

2007
Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
    Leukemia research, 2007, Volume: 31, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non

2007
Multidrug resistance in lymphoma: is it time for clinical trials?
    Leukemia & lymphoma, 2007, Volume: 48, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter,

2007
Granulocytic sarcoma in the absence of acute myeloid leukemia: a case report.
    Indian journal of pathology & microbiology, 2007, Volume: 50, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Diagno

2007
Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells.
    Cancer biology & therapy, 2008, Volume: 7, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X

2008
Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation.
    Experimental hematology, 2008, Volume: 36, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2008
Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy.
    International journal of hematology, 2007, Volume: 86, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemother

2007
Vulvar metastasis as the initial presentation of non-Hodgkin's lymphoma: a case report.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:11

    Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Bartholin's G

2007
Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis.
    Medical oncology (Northwood, London, England), 2008, Volume: 25, Issue:1

    Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal

2008
[Effect of corticoids on the activity of glucose-6-phosphate dehydrogenase in erythrocytes].
    Clinica chimica acta; international journal of clinical chemistry, 1967, Volume: 16, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Cortisone; Erythrocytes; Female; Glucosephosphate Dehydrogenase

1967
[Therapy of non-Hodgkin lymphomas of a high degree of malignancy].
    Folia haematologica (Leipzig, Germany : 1928), 1981, Volume: 108, Issue:5

    Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma; Lympho

1981
[2 cases of successful treatment of gastric lymphoma by means of polychemotherapy].
    Sovetskaia meditsina, 1984, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fema

1984
[Results of treatment of patients with lymphosarcoma according to the ACVP regimen].
    Terapevticheskii arkhiv, 1983, Volume: 55, Issue:8

    Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclop

1983
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group).
    European journal of cancer, 1980, Volume: 16, Issue:11

    Topics: Adolescent; Adult; Aged; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Femal

1980
Lactate dehydrogenase levels during MACOP-B chemotherapy for non-Hodgkin's lymphoma.
    Medical oncology and tumor pharmacotherapy, 1993, Volume: 10, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Cyclophosphamide; Doxo

1993
[Effect of combination chemotherapy for elderly patients with malignant lymphoma].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1993, Volume: 30, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1993
[Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen].
    Bulletin du cancer, 1993, Volume: 80, Issue:9

    Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosph

1993
[VEPA and ML-Y1 regimen for elderly non-Hodgkin's lymphoma].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1994, Volume: 31, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Fema

1994
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
    Leukemia & lymphoma, 1994, Volume: 13, Issue:1-2

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosp

1994
Intrapleural bleomycin in the treatment of chylothorax.
    Journal of chemotherapy (Florence, Italy), 1994, Volume: 6, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chylothorax; Cyclo

1994
Central nervous system lymphomas: progress in chemotherapy and radiotherapy.
    International journal of radiation oncology, biology, physics, 1995, Oct-15, Volume: 33, Issue:3

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials, Phase

1995
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
    Blood, 1995, Nov-15, Volume: 86, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marr

1995
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine

1995
A case of non-Hodgkin's lymphoma presenting with polyuria and acute renal insufficiency.
    Renal failure, 1995, Volume: 17, Issue:2

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclopho

1995
Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival.
    Cancer, 1993, May-01, Volume: 71, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hum

1993
Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
    The Ulster medical journal, 1993, Volume: 62, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Le

1993
Hepatitis after withdrawal of chemotherapy in a patient with chronic hepatitis B.
    The Journal of infection, 1993, Volume: 27, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto

1993
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1993
Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1995, Volume: 7, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Epirubicin; Fem

1995
Pemphigus foliaceus and non-Hodgkin's lymphoma.
    International journal of dermatology, 1994, Volume: 33, Issue:7

    Topics: Allopurinol; Chlorambucil; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Humans

1994
Aggressive non-Hodgkin's lymphoma in elderly patients: where to go from here?
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:9

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Su

1994
Avascular necrosis of bone following intensified steroid therapy for acute lymphoblastic leukaemia and high-grade malignant lymphoma.
    British journal of haematology, 1994, Volume: 86, Issue:1

    Topics: Adolescent; Adult; Dexamethasone; Humans; Knee Joint; Lymphoma, Non-Hodgkin; Magnetic Resonance Imag

1994
[Mycotic retrobulbar neuritis].
    Klinische Monatsblatter fur Augenheilkunde, 1994, Volume: 204, Issue:4

    Topics: Aged; Anemia, Aplastic; Diagnosis, Differential; Female; Humans; Lymphoma, Non-Hodgkin; Opportunisti

1994
[Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:15

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1993
[A case of malignant lymphoma of the thyroid accompanied by interstitial pneumonitis during radiation therapy after systemic chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration S

1994
[A comparative study of VEPA and ACOMEP-BD regimen for the patients with non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr

1993
[Malignant lymphoma following operation and chemotherapy of small cell lung carcinoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclo

1993
Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy.
    Cancer, 1993, Nov-01, Volume: 72, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immuno

1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans;

1993
Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms;

1995
[Autologous bone marrow transplantation as early therapy for patients with aggressive non-Hodgkin's lymphoma].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1996, Volume: 172, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxor

1996
Decreased lymphocytic proliferation by mitogens in patients with transitional cell carcinoma of the renal pelvis subsequent to non-Hodgkin's lymphoma.
    American journal of hematology, 1996, Volume: 51, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Transitional C

1996
Bulky centroblastic non-Hodgkin's lymphoma of the cranium vault mimicking brain involvement managed with chemotherapy: a case report.
    Cancer, 1995, Oct-01, Volume: 76, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Diagnosis, Differ

1995
Non-Hodgkin's lymphoma of the thyroid. A clinical study of twenty-two cases.
    Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Anti

1996
[Complete regression of cardiac non-Hodgkin's lymphoma after 23 months with chemotherapy].
    Archives des maladies du coeur et des vaisseaux, 1996, Volume: 89, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Echocardiography; Electrocardiogra

1996
Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia.
    Neuroradiology, 1996, Volume: 38, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Child; Child, Presc

1996
[Salvage therapy of relapsing or refractory malignant lymphoma with non-myelotoxic combined chemotherapy. Results of combination of cisplatin, bleomycin, methyl-GAG and prednisolone (Cis-BMP)].
    Bulletin du cancer, 1995, Volume: 82, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Hodgkin Disease;

1995
[New approach to the treatment of primary malignant non-Hodgkin's lymphoma of the stomach].
    Klinichna khirurhiia, 1996, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Ant

1996
[The combined chemoradiotherapy of lymphosarcomas].
    Terapevticheskii arkhiv, 1995, Volume: 67, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham

1995
Therapy-related leukemia with a novel 21q22 rearrangement.
    Cancer genetics and cytogenetics, 1996, Volume: 90, Issue:1

    Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 21;

1996
[Secondary non-Hodgkin lymphoma of the prostate: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 1996, Volume: 42, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom

1996
[Chemotherapy for two patients with non-Hodgkin's lymphoma in hemodialysis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hum

1996
Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
    JPMA. The Journal of the Pakistan Medical Association, 1996, Volume: 46, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; D

1996
[Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici

1996
F wave studies after intrathecal methotrexate administration.
    Acta neurologica Scandinavica, 1996, Volume: 94, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Drug Therapy, Combination; Humans; Inj

1996
[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital].
    Bulletin du cancer, 1996, Volume: 83, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophos

1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:9

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1996
Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
    International journal of radiation oncology, biology, physics, 1997, Jan-01, Volume: 37, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1997
Synchronous oesophageal carcinoma with non Hodgkin's lymphoma, problems with management.
    Indian journal of cancer, 1996, Volume: 33, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy;

1996
Malignant lymphoma of the mandible: report of a case.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1997, Volume: 83, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic

1997
Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
    The Journal of pediatrics, 1997, Volume: 130, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Child, Preschool; Diphosphonates; Glucoc

1997
Primary non-Hodgkin's lymphoma of the maxillary sinus.
    American journal of clinical oncology, 1997, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

1997
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Annales Academiae Medicae Stetinensis, 1996, Volume: 42

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, P

1996
[Primary extranodal non-Hodgkin's lymphoma of muscle tissue].
    Recenti progressi in medicina, 1997, Volume: 88, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Extremities; Female; Follow-

1997
Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1997
Non-Hodgkin's lymphoma trials in elderly look beyond CHOP.
    Journal of the National Cancer Institute, 1998, Feb-18, Volume: 90, Issue:4

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hu

1998
Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine.
    Bone marrow transplantation, 1998, Volume: 21, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; C

1998
Diagnosis and treatment of malignant lymphoma of the parotid gland.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclopho

1998
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
    Clinical and laboratory haematology, 1998, Volume: 20, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etop

1998
A cyclophosphamide-induced autoimmune diabetes.
    Lancet (London, England), 1998, Aug-01, Volume: 352, Issue:9125

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytog

1998
[A case of primary malignant lymphoma of the bladder].
    Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr

1998
Cell cycle dependency of 67gallium uptake and cytotoxicity in human cell lines of hematological malignancies.
    Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6

    Topics: Antineoplastic Agents; Biological Transport; Cell Cycle; Cell Division; Dose-Response Relationship,

1998
[Therapy-related MDS/leukemia carrying dup(11) (q21q23) with MLL gene tandem duplication].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:12

    Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Ch

1998
High-grade non-Hodgkin's lymphoma treated in northern Norway--treatment, outcome, and prognostic factors.
    Acta oncologica (Stockholm, Sweden), 1999, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined

1999
Cutaneous granulomas associated with high-grade T-cell non-Hodgkin's lymphoma.
    The British journal of dermatology, 1999, Volume: 140, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Granuloma; Humans; Lymphoma, Non-Hodgkin;

1999
Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

1999
Dose-escalation of CHOP in non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1999
Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1999, Volume: 11, Issue:3

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; H

1999
Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma.
    Bone marrow transplantation, 1999, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1999
Nephrostomy failure due to tumour lysis syndrome.
    Clinical radiology, 2000, Volume: 55, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Constriction, Pathologic; Cyclophosphamide; Doxorubi

2000
Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Daunorubicin; E

2000
Gastrointestinal mucormycosis complicated by arterio-enteric fistula in a patient with non-Hodgkin's lymphoma.
    Clinical and laboratory haematology, 2000, Volume: 22, Issue:1

    Topics: Amphotericin B; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophospham

2000
Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
    Leukemia & lymphoma, 2000, Volume: 38, Issue:3-4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Central Nervous System

2000
Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia.
    Acta haematologica, 2000, Volume: 103, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Histidi

2000
Renal relapse in bilateral synchronous testicular lymphoma.
    American journal of clinical oncology, 2000, Volume: 23, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide;

2000
Primary non-Hodgkin's lymphoma of the vagina.
    Haematologica, 2000, Volume: 85, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Sur

2000
[Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2000
Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.
    Annals of hematology, 2001, Volume: 80, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans;

2001
[High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2001, Volume: 42, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Et

2001
[Testicular malignant lymphoma: report of two cases].
    Hinyokika kiyo. Acta urologica Japonica, 2001, Volume: 47, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Doxo

2001
Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.
    Oncology (Williston Park, N.Y.), 2001, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F

2001
CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
    Experimental hematology, 2001, Volume: 29, Issue:12

    Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell

2001
[Angioendotheliomatosis proliferans systematizata].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:11

    Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic

2001
Ga-67 scintigraphy in patients with breast lymphoma.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ci

2002
[Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
    Zhonghua yi xue za zhi, 2001, Jul-10, Volume: 81, Issue:13

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspa

2001
A prolonged APTT in a patient with a low grade malignant NHL - a case report.
    Haematologica, 2002, Volume: 87, Issue:2

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Coagulation Factors; C

2002
Therapy for Australian cats with lymphosarcoma.
    Australian veterinary journal, 2001, Volume: 79, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cat Diseases; Cats; Cohort St

2001
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
    International journal of hematology, 2002, Volume: 75, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabin

2002
Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
    International journal of radiation oncology, biology, physics, 2002, Mar-01, Volume: 52, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th

2002
Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma.
    Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Ly

2002
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
    Acta haematologica, 1977, Volume: 57, Issue:5

    Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Com

1977
Immunologic studies of canine lymphosarcoma: mixed leukocyte reactivity following chemotherapy.
    Clinical immunology and immunopathology, 1978, Volume: 9, Issue:2

    Topics: Animals; Asparaginase; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Lymphocyte C

1978
[Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1977, Oct-28, Volume: 102, Issue:43

    Topics: Adult; Cyclophosphamide; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Dif

1977
Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
    Cancer, 1978, Volume: 41, Issue:1

    Topics: Bone Marrow; Chlorambucil; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; M

1978
[Results of treatment of lymphosarcoma according to the CVP program].
    Terapevticheskii arkhiv, 1978, Volume: 50, Issue:7

    Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Drug Thera

1978
Simple chemotherapy for bladder lymphoma with bilateral hydronephrosis.
    British journal of urology, 1978, Volume: 50, Issue:4

    Topics: Chlorambucil; Humans; Hydronephrosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Urinar

1978
Obstructed uropathy treated by chemotherapy.
    British journal of urology, 1979, Volume: 51, Issue:2

    Topics: Allopurinol; Cyclophosphamide; Female; Humans; Lymph Node Excision; Lymphoma, Non-Hodgkin; Middle Ag

1979
[Combination chemotherapy with vincristine, cyclophosphamide, procarbazine and prednisolone in advanced reticulum cell sarcoma (author's transl)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1976, Volume: 17, Issue:7

    Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Mal

1976
Uptake of 1-beta-D-arabinofuranosylcytosine and prednisolone by synchronized human lymphoma cells.
    Medical and pediatric oncology, 1976, Volume: 2, Issue:3

    Topics: Cell Division; Cell Line; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Prednisolone

1976
L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma.
    Haematologia, 1976, Volume: 10, Issue:2

    Topics: Adolescent; Anaphylaxis; Asparaginase; Child; Child, Preschool; Confusion; Daunorubicin; Female; Hal

1976
Steroid-induced remission in spinal canal reticulum cell sarcoma. Report of two cases.
    Journal of neurosurgery, 1975, Volume: 42, Issue:3

    Topics: Adolescent; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male;

1975
[Reticulosarcoma-like skin lesions in phenylketonuria (author's transl)].
    Monatsschrift fur Kinderheilkunde, 1975, Volume: 123, Issue:3

    Topics: Biopsy; Child; Child, Preschool; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Phenyl

1975
Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
    Acta medica Scandinavica, 1975, Volume: 197, Issue:4

    Topics: Adult; Aged; Bone Marrow; Chlorambucil; Drug Evaluation; Drug Therapy, Combination; Esters; Female;

1975
Mediastinal lymphosarcoma simulating pericarditis.
    Acta paediatrica Scandinavica, 1975, Volume: 64, Issue:6

    Topics: Child; Diagnosis, Differential; Diseases in Twins; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; M

1975
Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1992
[Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophos

1992
Malignant lymphoma in the mesentery with immune thrombocytopenia.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Immunogl

1992
[A case of the successful use of nitrosomethylurea in lymphosarcoma complicated by prolonged massive chylothorax].
    Voprosy onkologii, 1992, Volume: 38, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chylothorax; Cyclophosphamide; Female; Humans; Lymph

1992
[Lymphosarcoma of the stomach in children].
    Voprosy onkologii, 1992, Volume: 38, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Combined Modality

1992
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study.
    Cancer, 1992, Feb-01, Volume: 69, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclo

1992
Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients.
    Leukemia, 1992, Volume: 6 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Ly

1992
Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Li

1992
[Treatment of elderly patients with hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1992
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamid

1992
[THP-adriamycin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female;

1992
[The use of novantrone in combination with other preparations in hematosarcoma patients].
    Terapevticheskii arkhiv, 1992, Volume: 64, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1992
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, La

1992
AgNORs predictive value of prognosis in non-Hodgkin's lymphoma: comparison with flow cytometric cell cycle analysis.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:1-2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cyclophosphamide; DNA, Neoplasm; Doxorub

1992
[Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
    Annales de medecine interne, 1992, Volume: 143, Issue:3

    Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunos

1992
[A retrospective comparison study of patients old and young with non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:3

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami

1992
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Res

1992
[Combination chemotherapy (modified CHOP-Bleo) in non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici

1990
[Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C

1990
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

1991
[The results of the combined chemoradiation treatment of lymphosarcomas corresponding to the degree of its intensity].
    Terapevticheskii arkhiv, 1991, Volume: 63, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1991
[Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:12

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycl

1991
[Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
    Ugeskrift for laeger, 1991, Oct-14, Volume: 153, Issue:42

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin;

1991
Non-Hodgkin's lymphoma presenting at the site of a recent dental extraction: a report of two cases.
    The British journal of oral & maxillofacial surgery, 1991, Volume: 29, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Jaw Neoplasms; Ly

1991
Nonlymphoblastic lymphoma in children--histology and stage-related response to therapy: a Pediatric Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined

1991
Non-Hodgkin's lymphoma in pregnancy.
    Asia-Oceania journal of obstetrics and gynaecology, 1990, Volume: 16, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Female; Fetus

1990
Non-Hodgkin's lymphoma. A four-drug regimen suitable for elderly patients with advanced disease.
    Acta oncologica (Stockholm, Sweden), 1990, Volume: 29, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Drug Evaluation; Female; Humans;

1990
[Primary malignant lymphoma of the urinary bladder: report of a case].
    Hinyokika kiyo. Acta urologica Japonica, 1990, Volume: 36, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Combined Modality Therapy; Cyc

1990
Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphoma.
    Oncology, 1990, Volume: 47, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female;

1990
The role of azathioprine in the management of ulcerative colitis.
    Diseases of the colon and rectum, 1990, Volume: 33, Issue:5

    Topics: Adult; Azathioprine; Colitis, Ulcerative; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; M

1990
UKALL X--an effective treatment for stage III mediastinal non-Hodgkin's lymphoma.
    Archives of disease in childhood, 1990, Volume: 65, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D

1990
Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.
    Cancer, 1990, May-01, Volume: 65, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined M

1990
Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.
    British journal of cancer, 1990, Volume: 62, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Resp

1990
[Epirubicin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma: with emphasis of elderly patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclo

1990
[Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1987
Failure of conventional chemotherapy in aggressive lymphomas.
    Postgraduate medical journal, 1987, Volume: 63, Issue:735

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici

1987
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide;

1989
Endobronchial non-Hodgkin's lymphoma.
    Respiratory medicine, 1989, Volume: 83, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Cyclophosphamide; Do

1989
[Chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in stages I to II of the disease].
    Terapevticheskii arkhiv, 1989, Volume: 61, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1989
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:2

    Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide;

1989
Resolution of lymphosarcoma associated blindness in a dog following chemotherapy.
    The Veterinary record, 1989, Sep-09, Volume: 125, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blindness; Cyclophosphamide; Dog Diseases;

1989
Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin's lymphoma.
    American journal of clinical oncology, 1989, Volume: 12, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; D

1989
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposid

1989
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas].
    Sangre, 1989, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug

1989
Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:5

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; D

1989
[Adjuvant chemotherapy for stage I and II non-Hodgkin's lymphoma--a seven-year follow up].
    Nihon Gan Chiryo Gakkai shi, 1989, Jul-20, Volume: 24, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha

1989
Is steroid psychosis preventable by divided doses?
    Lancet (London, England), 1986, Dec-13, Volume: 2, Issue:8520

    Topics: Adult; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Psyc

1986
[A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report].
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1988, Volume: 41, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1988
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
    Cancer genetics and cytogenetics, 1988, Volume: 36, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin D

1988
[THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubic

1988
[Effect of combination chemotherapy with cis-dichlorodiammineplatinum on relapsed or therapy-resistant non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubici

1988
[A primary malignant lymphoma of the vulva--a case report].
    Gan no rinsho. Japan journal of cancer clinics, 1988, Volume: 34, Issue:15

    Topics: Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Combined Modality

1988
[Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Prot

1988
Long-term comparison of results of a drug sensitivity assay in vitro with patient response in lymphatic neoplasms.
    Cancer, 1988, Mar-15, Volume: 61, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Drug Screening

1988
[Clinical study on advanced non-Hodgkin's lymphoma with special reference to the results of chemotherapies with ACOP, ACOP-E and AclBEP regimen].
    Nihon Gan Chiryo Gakkai shi, 1987, Jul-20, Volume: 22, Issue:6

    Topics: Aclarubicin; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

1987
[Clinical analysis of 82 patients with non-Hodgkin's lymphoma--mainly on the evaluation of therapeutic efficacy].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1987, Volume: 62, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined

1987
Three cases of secondary leukemia. Clinicopathologic findings.
    Acta pathologica japonica, 1987, Volume: 37, Issue:5

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fema

1987
Isolated bilateral T-cell renal lymphoblastic lymphoma.
    The American journal of pediatric hematology/oncology, 1986,Spring, Volume: 8, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Doxorubicin; Female; Humans; Kidne

1986
Haemorrhage and perforation of gastrointestinal neoplasms during chemotherapy.
    Annals of the Royal College of Surgeons of England, 1986, Volume: 68, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Femal

1986
[Therapeutic results in 22 cases of childhood non-Hodgkin's lymphoma treated by ACOP combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1987
Salvage chemotherapy for non-Hodgkin's lymphoma with a combination of mitoxantrone, etoposide, cisplatin, and prednisolone.
    Cancer treatment reports, 1987, Volume: 71, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; L

1987
Intraocular large cell lymphoma presenting as massive thickening of the uveal tract.
    Retina (Philadelphia, Pa.), 1987,Spring, Volume: 7, Issue:1

    Topics: Diagnosis, Differential; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Predniso

1987
[Clinico-hematological effect of spirobromin in chronic lympholeukemia amd malignant non-Hodgkin's lymphoma].
    Gematologiia i transfuziologiia, 1987, Volume: 32, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cyclophospha

1987
Mediastinal malignant lymphoma complicated with esophagobronchial fistula: successfully treated case.
    Japanese journal of clinical oncology, 1987, Volume: 17, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchial Fistula; Combined Modality Therapy

1987
[Possibility of the comparative evaluation of chemotherapy effectiveness in hemoblastoses in man and dogs].
    Vestnik Akademii meditsinskikh nauk SSSR, 1986, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxor

1986
[Clinical picture and treatment of lesions of the epidural space in lymphosarcoma].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi

1986
[Therapy against relapse in generalized lymphoblastic and immunoblastic lymphosarcomas in complete remission].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Eval

1986
[A preliminary study of chemo-interferon therapy in malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm

1987
[Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1986, Volume: 49, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham

1986
[Salvage chemotherapy of non-Hodgkin's lymphoma with a four-drug combination of mitoxantrone, etoposide, cisplatin and prednisolone (MEPP)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:3 Pt 1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etopos

1987
Non-Hodgkin's lymphoma in pregnancy.
    Southern medical journal, 1985, Volume: 78, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow

1985
[Results of the treatment of lymphosarcoma of the large intestine].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Cecum; Colectomy; Colonic Neoplasms

1985
[Clinico-morphological analysis of chemotherapy effectiveness in spontaneous hemoblastoses in dogs].
    Voprosy onkologii, 1985, Volume: 31, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Drug

1985
[Results of polychemotherapy in neoplasms of the lymphoreticular system].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1973, May-01, Volume: 28, Issue:9

    Topics: Antineoplastic Agents; Cyclophosphamide; Hodgkin Disease; Humans; Infections; Leukopenia; Long-Term

1973
Paraplegia in childhood malignant disease.
    Acta paediatrica Scandinavica, 1967

    Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Female; Humans; Infant; Leukemi

1967
[Adriamycin in the therapy of child leukemias and tumors].
    Monatsschrift fur Kinderheilkunde, 1973, Volume: 121, Issue:7

    Topics: Acute Disease; Adolescent; Doxorubicin; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neo

1973
Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency.
    Journal of neurology, neurosurgery, and psychiatry, 1973, Volume: 36, Issue:5

    Topics: Adrenocorticotropic Hormone; Brain Neoplasms; Cerebral Ventricles; Cerebrospinal Fluid Proteins; Cra

1973
Temporary resolution of geographic tongue with cytotoxic therapy.
    Australian paediatric journal, 1974, Volume: 10, Issue:4

    Topics: Child; Drug Therapy, Combination; Glossitis, Benign Migratory; Humans; Lymphoma, Non-Hodgkin; Male;

1974
Reticulosarcoma of the vulva complicating dermatomyositis treated by immunosuppression.
    Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:4

    Topics: Adult; Azathioprine; Dermatomyositis; Erythema; Female; Humans; Immunosuppressive Agents; Lymphoma,

1973
Primary reticulum cell sarcoma of the brain in a renal transplantation recipient.
    Journal of neurosurgery, 1974, Volume: 41, Issue:2

    Topics: Abscess; Adult; Azathioprine; Brain Neoplasms; Chronic Disease; Epididymitis; Frontal Lobe; Glomerul

1974
Malignant lymphomas in children. A clinico-pathologic retrospective study. II. Non-Hodgkin's lymphomas.
    Acta paediatrica Scandinavica, 1974, Volume: 63, Issue:5

    Topics: Adolescent; Bone Marrow Diseases; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Femal

1974
Cerebral reticulum cell sarcoma after multiple renal transplants.
    Journal of neurology, neurosurgery, and psychiatry, 1974, Volume: 37, Issue:8

    Topics: Adult; Azathioprine; Brain Neoplasms; Dactinomycin; Glomerulonephritis; Humans; Immunosuppression Th

1974
[Complex treatment of reticulosarcoma and lymphosarcoma patients].
    Klinicheskaia meditsina, 1974, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-

1974
Haemolytic anaemia in malignant lymphoreticuloendothelial diseases.
    Haematologia, 1974, Volume: 8, Issue:1-4

    Topics: Adult; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Autoantibodies; Bone Marrow Examination; Ce

1974
[Problems concerning differential diagnosis in transvers leasions of the spinal cord (author's transl)].
    Medizinische Klinik, 1973, Oct-15, Volume: 68, Issue:42

    Topics: Adolescent; Arterial Occlusive Diseases; Cervical Vertebrae; Diagnosis, Differential; Diagnostic Err

1973
Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.
    Cancer research, 1970, Volume: 30, Issue:8

    Topics: Animals; Cell Transformation, Neoplastic; Depression, Chemical; Female; Leukemia, Experimental; Leuk

1970
Cytologic studies of tumors. L. clonal proliferation of four stemlines in three hematopoietic tissues of a patient with reticulosarcoma.
    Blood, 1971, Volume: 37, Issue:1

    Topics: Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Chromosome Aberrations; Culture Techniques;

1971
Combination chemotherapy in malignant disease.
    Clinical radiology, 1971, Volume: 22, Issue:4

    Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Fem

1971
Combination chemotherapy with L-asparaginase (EC-2) using P1798 lymphosarcoma.
    Cancer, 1971, Volume: 28, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cyclophosphami

1971
Glucocorticoid inhibition of precursor incorporation into nuclear RNA of P1798 lymphosarcoma.
    Biochimica et biophysica acta, 1971, Mar-11, Volume: 232, Issue:2

    Topics: Animals; Carbon Isotopes; Cell Biology; Cell Nucleus; Centrifugation, Density Gradient; Chromatograp

1971
Lymphosarcoma of lacrimal gland.
    The Laryngoscope, 1971, Volume: 81, Issue:9

    Topics: Aged; Exophthalmos; Eye Neoplasms; Female; Humans; Lacrimal Apparatus; Lymphoma, Non-Hodgkin; Predni

1971
L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.
    JAMA, 1967, Nov-27, Volume: 202, Issue:9

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Humans; Leukemia, Lymphoid; Leukemia, Myeloi

1967
[Modern aspects of treatment of acute leukemia].
    Vestnik Akademii meditsinskikh nauk SSSR, 1968, Volume: 23, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Child; Female; Humans; Leukemia, Lymphoid

1968
High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
    Annals of internal medicine, 1967, Volume: 66, Issue:6

    Topics: Adolescent; Adult; Aged; Cortisone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hodgkin Di

1967
[Study of combined action of bruneomycin and prednisolone on the development of mouse lymphosarcoma (strain LIO-1)].
    Antibiotiki, 1968, Volume: 13, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Drug Synergism; Lymphoma, Non-Hodgkin; Mice; Prednisolone

1968
The management of hypercalcaemia in malignant disease.
    The Medical journal of Australia, 1965, Sep-04, Volume: 2, Issue:10

    Topics: Adult; Breast Neoplasms; Diet Therapy; Humans; Hydrocortisone; Hypercalcemia; Lymphoma, Non-Hodgkin;

1965
Inhibition of 11-beta-hydroxysteroid dhydrogenase activity in rat and mouse tissues in vitro and in vivo.
    Endocrinology, 1965, Volume: 77, Issue:2

    Topics: Animals; Blood; Cortisone; Enzymes; Hydrocortisone; Hydroxyprogesterones; Hydroxysteroid Dehydrogena

1965
Albumin turnover in pleural effusions.
    Clinical science, 1965, Volume: 29, Issue:2

    Topics: Administration, Topical; Anti-Inflammatory Agents; Breast Neoplasms; Capillary Permeability; Heart F

1965
The role of ribonuclease in regression of lymphosarcoma P1798.
    Cancer research, 1966, Volume: 26, Issue:5

    Topics: Animals; Chloromercuribenzoates; Chromatography; Corticosterone; Fluorouracil; Freezing; Hydrocortis

1966